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ZUSAMMENFASSUNG 
Zytotoxische T Lymphozyten (CTLs) töten Zielzellen durch die Freisetzung von Substanzen aus 
sogenannten zytotoxischen Granulen (CGs). Da CTLs in der Lage sind, mehrere Zielzellen 
sequentiell zu töten, werden sie auch als „Serial Killers“ bezeichnet. Voraussetzung für diesen 
Prozess ist ein schnelles Erneuern von CGs. Diese Erneuerung könnte durch komplette de novo 
Synthese erfolgen oder aber durch Recycling noch verwendbarer Komponenten mit partieller 
Neusynthese. Um das Recycling besser zu verstehen, haben wir den endocytotischen Weg von 
Synaptobrevin2 (Syb2), dem v-SNARE von CGs von Maus-CTLs untersucht. Diese 
Untersuchungen wurden an CTLs von Syb2-mRFP Knockin (Sybki) Mäusen durchgeführt. 
Durch Exozytose an die Oberfläche gelangtes Syb2-mRFP (weiterhin abgekürzt als Syb2) wurde 
mit anti-mRFP Antikörpern markiert und so die folgende Endozytose und Prozessierung in den 
CTLs untersucht. 
Wir begannen unsere Studie am Zeitpunkt der Fusion CGs mit der Plasmamembran. Durch Co-
Immunopräzipitationsexperimente konnten wir zeigen das Syb2 mit dem synaptosomal-
assoziierten Protzein-23 (SNAP-23) während der SNARE-Komplexbildung assoziiert. Diese 
Interaktion dürfte der Fusion von CGs mit der Plasmamembran dienen. SNAP-23 ist als 
wahrscheinlich ein t-SNARE der CG Fusion. Nach der Fusion von CGs mit der Plasmamembran 
erscheint das an Syb2 fusionierte mRFP auf der Zelloberfläche. Die Benutzung Fluoreszenz-
markierter anti-RFP Antikörper erlaubt dann das Verfolgen von Syb2 während des 
endozytotischen Prozesses. Wir konnten verschiedene Proteine identifizieren, die, zumindest bis 
zur Fusion mit Early Endosomes (frühen Endososmes), zusammen mit Synaptobrevin2 im selben 
Vesikel auftraten und somit gleichzeitig endozytiert wurden. Proteine, die mit Synaptobrevin2 
endozytiert wurden sind das t-SNARE SNAP23, das zeta-Kette- assozierte-70 kDA-Tyrosin-
Phoshoprotein (ZAP70) und das CG-Membranprotein H+ V-ATPase. Diese Ergebnisse wurden 
mit hochauflösender Fluoreszenzmikroskopie erhoben, wobei Proben vor der Untersuchung zu 
unterschiedlichen Zeitpunkten nach Stimulation fixiert wurden. Die Endozytose der V-ATPase 
zusammen mit Syb2 wurde außerdem durch live cell Experimente verifiziert, bei denen das 
Ansäuern endozytierter und Syb2-enthaltender Vesikel innerhalb von nur 1-2 Minuten nach 
Stimulation der Zellen gezeigt werden konnte. Endozytiertes Syb2 erreichte 15 min nach dem 
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initialen Stimulus Early Endosomes (frühe Endosomen), wie durch Kolokalisation mit eGFP-
RAB5 (einem Early Endosome Marker) gezeigt wurde. Nach 60 min schließlich erreichte 
endozytiertes Syb2 die Late Endosomes (späte Endosomen, Marker eGFP-RAB7). Hingegen 
konnten wir kein endozytiertes Syb2 in Recycling Endosoms (Marker eGFP-Rab11) finden. Um 
herauszufinden, ob Vesikel, die endozytiertes Syb2 enthalten, zu neuen zytotoxischen Granulen 
heranreifen, haben wir untersucht, ob diese Vesikel das als Marker für reife zytotoxische 
Granulen geltende apoptotische Protein GranzymB aufnehmen. Wir fanden, dass GranzymB mit 
Syb2 nach 60 min kolokalisiert, also nach derselben Zeit der maximalen Kolokalisation mit Late 
Endosomes. 
Unsere Studie identifiziert SNAP-23 als t-SNARE, das mit dem V-SNARE Syb2 interagiert um 
die Fusion von CGs zu initiieren. Außerdem wird gezeigt, das exozytiertes Syb2 zusammen mit 
anderen Komponenten von CGs endozytiert wird und während der Reifung lediglich fehlende 
Proteine wie Granzym B neu eingebaut werden. Dieser Prozess könnte für das „Serial Killing“ 
von CTLs wichtig sein. 
INTRODUCTION 
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I. Introduction 
I.1 The Immune system 
I.1.1 Innate vs. adaptive immune systems 
The immune system consists of two main branches: the innate and the adaptive immune systems. 
The skin and epithelial tissues constitute the first line of defense of the innate system. They 
function to prevent the entry of pathogens into the host tissue by rapidly eliminating them, 
carried out by the action of innate immune cells such as neutrophils, phagocytes and natural 
killer (NK) cells. When a pathogen escapes the action of innate immune cells, the highly specific 
and more effective cells of the adaptive immune system comes into action (Medzhitov and 
Janeway, 2000). The adaptive immune system consists of humoral and cellular responses. The 
humoral response is generated by B lymphocytes that upon activation differentiate into plasma 
cells, which produce antibodies against the invading pathogen. These specific antibodies 
neutralize extracellular microbes and prevent their entry into host cells allowing cells of the 
innate immune system to phagocytose and eliminate them. The second response known as the 
cellular response is performed by another subset of lymphocytes known as T lymphocytes, these 
are either CD4+ (Th cells) or CD8
+ cells (known as cytotoxic T lymphocytes (CTLs) upon 
activation). Initially, lymphocytes are synthesized as naïve cells. Such cells possess a specific 
receptor for a specific antigen but are not functionally active. Upon encounter with an 
appropriate antigen, presented as an antigen-MHC complex on the surface of an antigen 
presenting cell (APC), peptides presented by MHC class I are recognized by CD8+ cells and 
peptides presented by MHC class II are recognized by B cells and CD4+ cells, the lymphocyte 
carrying the corresponding receptor is activated and induced to proliferate in a process known as 
clonal expansion. This activation process produces copies of lymphocytes carrying the same 
receptor (clones), which are then able to carry out their effector function against their target. 
Effector CD4+ cells produce cytokines that activate phagocytes and other lymphocytes including 
B cells and CD8+ cells. Activated CD8+ cells or CTLs are then able to induce death of target 
cells (Figure 1) (Abbas et al., 2015) (Dempsey et al., 2003; Gasteiger and Rudensky, 2014). 
INTRODUCTION 
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Figure 1. Cellular response of the adaptive immune system.  
Different types of pathogens activate different subsets of T cell lymphocytes. CD4+ T cells differentiate into helper 
T lymphocytes (Th) (upper panel) upon encounter with an APC carrying bacterial antigens on MHC class II. Th 
cells then produce cytokines that activate innate immune cells and other lymphocytes. CD8+ T cells differentiate into 
cytotoxic T lymphocytes (CTLs) (lower panel) when the T cell receptors (TCR) recognize viral antigens bound to 
MHC class I presented by an APC. This process activates CTLs, so upon encounter with an infected cell they release 
cytotoxic proteins that lead to target cell apoptosis. APC, antigen-presenting cell; MHC, major histocompatibility 
complex (Abbas et al., 2015). 
I.1.2 Cytotoxic T Lymphocytes (CTLs) 
Activated CD8+ T cells or cytotoxic T lymphocytes are known as the killer cells of the adaptive 
immune system. They derive their name from their ability to kill virally-infected and tumor cells 
by releasing the content of their cytotoxic granules (CGs), perforin and granzyme, which are then 
taken up by the target cell resulting in its death (Zhang and Bevan, 2011). 
Naïve CD8+ T cells carry T cell receptors (TCRs), which are specific to a single peptide. There 
are millions of T cell clones, i.e. carrying TCRs with different specificity against a wide 
spectrum of pathogens. Initial activation of naïve CD8+ T cells require that they get in contact 
with an antigen presenting cell (APC), which presents an appropriate peptide on an MHC class I 
molecule. The foreign peptides presented by MHC class I molecules are derived from cytosolic 
pathogens such as viruses. For this reason, CD8+ T cells which recognize these peptide-MHC I 
complexes, usually mediate the response to a viral infection (Figure 1, lower panel). Upon TCR 
INTRODUCTION 
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recognition of a specific peptide presented as an MHC I-peptide complex, CD8+ T cells which 
patrol the blood and lymphatic systems decrease their rate of migration, and remain in the region 
of contact with their APCs. This usually occurs in the peripheral lymphoid organs. This cessation 
of motion is the result of interaction of cell-cell adhesion molecules (Dustin and Springer, 1989). 
Once a CD8+ T cell is activated it increases the expression of activation markers, upregulates the 
expression of cytotoxic proteins, secretes cytokines and proliferate to induce a more efficient 
clearance of the pathogen. Activated or effector CTLs have a short life, but some remain as 
memory cells which can initiate a faster and stronger response upon a repeated encounter to the 
same antigen specific to their TCR (Abbas et al., 2015).  
I.1.2.1 Immunological synapse 
The TCR-pMHC I (peptide-MHC I) interaction leads to the formation of a close contact between 
the CD8+ T cell and the APC (target cell). This contact is called the immunological synapse (IS). 
The initial IS, also known as the signaling synapse, is long lasting and is formed to activate a 
naïve CD8+ T cell against a specific pathogen thus inducing effector CTL differentiation. The 
second IS is short lived, lasting for about 20 to 30 min. It is formed between a fully activated 
CTL and its target: in this case the CTL polarizes its newly formed CGs towards the IS directly 
upon contact with their target where the CGs fuse with the plasma membrane and release their 
content, inducing target cell death. Both types of synapses are structurally similar, with 
compartmentalization into three areas, a central area called central supra molecular activation 
cluster (cSMAC) surrounded by a peripheral ring called the pSMAC which is surrounded by a 
distal area called the dSMAC (Figure 2) (Grakoui et al., 1999; Monks et al., 1998). Upon initial 
contact of the CTL with the target cell, their contact area is rich with polymerized actin (Ryser et 
al., 1982), which then moves rapidly (after around one minute) towards the periphery of the 
newly formed IS to clear the center for the TCR microclusters which translocate laterally from 
the pSMAC upon actin network reorganization (Campi et al., 2005; Varma et al., 2006). A 
second wave of TCR arrives at the IS later with the polarizing centrosome about 4 to 6 minutes 
after IS formation (Das et al., 2004; Ritter et al., 2015). The polarizing centrosome (Kupfer and 
Singer, 1989) also directs the accumulating CGs on the microtubules towards the CTL-target 
contact site (Geiger et al., 1982; Ritter et al., 2015; Stinchcombe et al., 2001b; Stinchcombe et 
al., 2006) where they fuse with the CTL plasma membrane in a specialized secretory domain 
within the cSMAC, releasing their toxic cargo (Peters et al., 1989) (See Figure 2). The 
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interaction between the TCR and the peptide-MHC I complex presented on the APC or target 
cell accounts for the 13 nm distance between the two interacting cells (Choudhuri et al., 2005). 
Other components of the cSMAC include members of the Src-family kinases, Lck and Fyn, 
which interact with the cytosolic domain of the CD3 receptor. These molecules are recruited in 
the first minutes of TCR-peptide interaction and can be used as the markers for early IS 
formation (Beal et al., 2009). The pSMAC contains adhesion molecules like lymphocyte 
function-associated antigen 1 (LFA-1), found on the T cell surface, which interacts with 
intercellular Adhesion Molecule 1 (ICAM-1) located on the target cells’ membrane, inducing the 
formation of a tight contact between the CTL and the target cell (Monks et al., 1998; Potter et al., 
2001). The cytosolic tail of LFA-1 binds to talin, causing its aggregation at the cSMAC. The 
reorganized actin clusters at the periphery of the IS to form the dSMAC, which is also the site for 
the accumulation of the phosphatase CD45 that is responsible for the activation of many 
signaling proteins (Freiberg et al., 2002). 
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Figure 2. Organization of the immunological synapse (IS).  
The contact formed between the CTL and the target cell, the IS, is shown here in detail. In the central area called 
cSMAC (central SMAC), the TCR clusters on the T cell membrane binding to the peptide-MHC I complex on the 
target cell membrane (green). The lytic granules or CGs fuse in the area around the TCR (red). The pSMAC 
(peripheral SMAC) surrounds the cSMAC and it contains the adhesion molecule LFA-1 on the CTL membrane, 
binding to ICAM on the target cell membrane and surrounded by actin localized to the dSMAC (distal SMAC). 
CTL, cytotoxic T lymphocyte; ICAM, Intercellular Adhesion Molecule; LFA-1, lymphocyte function-associated 
antigen 1; SMAC, supra molecular activation cluster (Jenkins and Griffiths, 2010).   
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I.1.2.2 Cytotoxic granules (CGs) of CTLs  
CTLs are able to kill target cells because they contain organelles called cytotoxic granules (CGs) 
that contain cytotoxic proteins. CGs are also known as secretory lysosomes because they harbor 
many of the protein content found in or on conventional lysosomes (Burkhardt et al., 1990; 
Peters et al., 1991), such as the lysosomal transmembrane proteins, acid hydrolases and others. 
Among the membrane proteins of CGs, are the lysosomal associated membrane proteins 
(LAMP-1 and LAMP-2, and LAMP-3 or CD63), Fas-ligand (FasL), the V-type H+ ATPase, and 
the v-SNARE synaptobrevin2 (Syb2). Most membrane proteins are recognized by one of the 
adaptor proteins (AP-1, -2, and -3) depending on their location whether on endosomes, the 
plasma membrane, or the Golgi respectively, where they are then exported to reach the CGs via 
lysosomes. LAMP proteins are heavily glycosylated and constitute up to 50% of the lysosomal 
membrane proteins (Fukuda, 1991); the N-glycosylated regions of LAMP proteins are exposed 
to the lumen of lysosomes. They are thought to be responsible for the protection of the lysosomal 
membrane from the action of the lumenal soluble hydrolases. LAMP-1 and -2 (also called 
CD107a and b, respectively) are frequently used as markers for degranulation of lysosomes in 
CTLs (Betts et al., 2003). FasL, another membrane component of CGs, is incorporated into the 
CTL membrane upon CG fusion; it is then cleaved by extracellular proteases producing a soluble 
FasL which can bind to the Fas receptor (CD95) on the surface of the target cell inducing its 
apoptosis (Dhein et al., 1995). The V-ATPase (see below) is involved in maintaining the acidic 
pH of CGs (pH 5.5-4.5) (Burkhardt et al., 1990) that is required to keep the cytotoxic proteins in 
an inactive state in the vesicle. As a requirement for fusion, CGs require a vesicle-associated 
SNARE protein (v-SNARE, see also I.2); Matti et al showed that Syb2 was the v-SNARE 
required for fusion in mouse CTLs (Matti et al., 2013); Syb2 localized to CGs containing 
granzyme B, which are characterized by an electron dense core. The author and his colleagues 
also found that CG fusion is aborted in CTLs treated with tetanus toxin that cleaves Syb2 (Matti 
et al., 2013).  
 CGs also contain a number of soluble proteins. The cytotoxic proteins perforin and granzyme, 
the lysosomal hydrolases such as cathepsins and the chondroitin sulfate proteoglycans 
(serglycin) are found in CGs. Serglycin gives the CGs their electron dense structure and it binds 
the cytotoxic proteins to keep them inactive while still inside the vesicle (Blott and Griffiths, 
2002; de Saint Basile et al., 2010). Cytotoxic proteins are initially synthesized as inactive 
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precursors. Perforin, the pore forming protein, is synthesized as a 70-kDa inactive precursor with 
N-terminal glycosylation that is processed into the active form upon entry into the CGs. 
Activation of perforin entails the removal of a 10-20 amino acid stretch from the C-terminus 
exposing a phospholipid-binding C2 domain. Perforin is then able to bind lipid membranes via 
this domain in a calcium-dependent manner (Uellner et al., 1997). Perforin’s C-terminus and its 
N-linked glycans are important for its traffic from the ER to the Golgi and finally to the CGs 
(Brennan et al., 2011). Calreticulin, a calcium binding protein, plays an important role in 
inhibiting the function of perforin inside the CG, along with the serglycin complex (Fraser et al., 
2000; Masson et al., 1990). The other family of CG cytotoxic proteins, granzymes, belongs to the 
group of serine esterases. There are about eight identified granzymes in mouse CTLs (A, B, C, 
D, E, F, G and H) (Masson and Tschopp, 1987). Granzyme B, for example, is synthesized as a 
pro-enzyme that is activated at the CGs by the cleavage of an N-terminal dipeptide by a group of 
redundant lysosomal hydrolases (cathepsins) (D'Angelo et al., 2010). Granzymes A and B, as 
well as some lysosomal proteins such as cathepsin B, are targeted to the CGs via mannose-6-
Phosphate receptor (Griffiths and Isaaz, 1993).  
Upon CG fusion and release of cytotoxic proteins, perforin is thought to aid in granzyme 
penetration into the target cell either by forming pores in the target’s plasma membrane (Podack 
and Hengartner, 1989) or by being endocytosed into the target in vesicles together along with 
granzyme, and then forming pores in the vesicle membrane to allow for access of granzyme into 
the target’s cytosol (Shi et al., 1997). Also cathepsin B, a soluble enzyme of CGs, relocates to the 
CTL membrane upon CG fusion, thus protecting the CTL from self-suicide by cleaving the 
cytotoxic proteins that are directed back towards the CTL (Balaji et al., 2002).  
I.2 Soluble N-ethylmaleimide-sensitive factor attachment protein receptor 
(SNARE) proteins 
Intracellular fusion processes occur via coordinated molecular fusion machinery in order to 
ensure cargo transfer in eukaryotic cells. Cargo-containing vesicles’ fusion with the membrane 
of the destination organelle provides the cargo at the correct place and time. For example, release 
of cytotoxic proteins into the immunological synapse (IS) occurs by fusion of CG membrane 
with the plasma membrane (PM) of the CTL. This fusion process, like intracellular fusion 
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processes, occurs by the concerted action of a group of proteins involved in membrane fusion 
called SNARE (soluble N-ethylmaleimide-sensitive factor attachment protein (SNAP) receptor) 
proteins (Hanson et al., 1997; Lin and Scheller, 1997). SNAREs are sorted to different 
membranes depending on the group to which they belong. Early classification determined two 
groups of SNAREs, v-SNAREs (located to the vesicle membrane or donor membrane) and 
t-SNAREs (located to the target membrane). SNARE proteins interact with each other via the 
highly conserved SNARE motif (α-helix, ~ 60 amino acids) contributed from each SNARE 
protein. The crystal structure of the core SNARE complex determined by Sutton and his 
colleagues (Sutton et al., 1998) provided more insight into the nature of interaction between the 
different SNARE motifs showing the tight interaction between the arginine (R) or glutamine (Q) 
amino acids at the zero layer of the formed SNARE complex (Figure 3). A new terminology 
based on the central functional residue of the SNARE motif of each SNARE protein involved in 
the complex, whether it’s an R (termed R-SNAREs) or a Q (termed Q-SNAREs) amino acid 
(Fasshauer et al., 1998) was then developed. Q-SNAREs can be further classified as Qa-, Qb-, 
Qc- or Qb,c-SNAREs depending on how their α-helix is positioned within the trans-SNARE 
complex. R-SNAREs and most Q-SNAREs contribute one α-helix to the SNARE complex 
except for the Qb,c-SNARE proteins which contribute 2 α-helices. One R- and two or three Q-
SNAREs (Qa, Qb,c or Qa, Qb, Qc) on opposing membranes form a trans-SNARE complex 
bringing the two membranes into close proximity, inducing membrane fusion thus forming the 
transient cis-SNARE complex (Hanson et al., 1997; Weber et al., 1998). The cis-SNARE 
complex is then disassembled due to the ATPase activity of N-ethylmaleimide-sensitive fusion 
factor (NSF) protein, which binds the complex through α-SNAP (Sollner et al., 1993a; Sollner et 
al., 1993b). 
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Figure 3. Topology of the SNARE complex fusion machinery.  
a, Ribbon illustration of the SNARE complex: blue, synaptobrevin2 (Sb); red, syntaxin-1A (Sx); green, SNAP-25B 
(Sn1 and Sn2). b, Organization of SNARE proteins within the SNARE complex. C α traces (grey), local helical axes 
(blue, red and green for synaptobrevin2, syntaxin-1A and SNAP-25B, respectively), the superhelical axis (black), 
and layers (0, red; -1, +1 and +2, blue; all others black) of the complex are shown. Virtual bonds between 
corresponding C α positions represent the different layers (Sutton et al., 1998). 
I.2.1 Function of SNARE proteins 
The first indication that SNARE proteins mediate membrane fusion was their identification as 
targets for clostridial botulinum and tetanus toxins including Syb2 (Schiavo et al., 1992), 
SNAP-25 (Blasi et al., 1993a), and STX1 (Blasi et al., 1993b). These three proteins were found 
to form a complex together that is dissociated by the ATPase NSF protein (Sollner et al., 1993a). 
This discovery led to the suggestion that SNARE proteins bring opposing membranes closer 
together and induce their fusion. Although SNARE proteins constitute the minimal fusion 
machinery, many other proteins are required for the regulation of the exocytosis process at the 
different steps of docking, priming and fusion.  
I.2.1.1 Docking 
Docked or tethered vesicles are located close to the plasma membrane, however they are not 
fusion competent until they are primed, i.e. they are able to fuse directly in response to elevated 
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calcium signals. Although the proteins involved in docking are still poorly identified, it is 
thought that members of the sec1/Munc18 family might be involved in docking (Becherer and 
Rettig, 2006). Munc18-1 deletion abolishes secretion in neurons and neuroendocrine cells. This 
effect is probably mediated by different interactions in different cell types, as the number of large 
dense core vesicles (LDCVs) at the plasma membrane is reduced in chromaffin cells (Voets et 
al., 2001), however the number of synaptic vesicles at the active zone is not affected (Verhage et 
al., 2000). Munc18-1 can bind directly to syntaxin and regulate its availability for interaction 
with other SNARE proteins or its stability and turnover (Dulubova et al., 1999).  
I.2.1.2 Priming   
Priming docked vesicles, i.e. rendering them fusion competent is better understood than docking. 
Priming is initiated by the formation of the ternary SNARE complex composed of one 
R-SNARE and two or three Q-SNAREs. The SNARE complex is characterized by its stability as 
it is known to be SDS-resistant and shows high thermostability (Fasshauer et al., 1997). The 
Munc13’s are critical for the priming process (Brose et al., 2000). There are four isoforms of the 
Munc13 family, Munc13-1, -2, -3 and -4. In hippocampal neurons for example, where only 
Munc13-1 and Munc13-2 are expressed, vesicle fusion is entirely abolished in Munc13-1/2 
double KO mice (Varoqueaux et al., 2002). Munc13-1 is thought to mediate the release of 
Munc18-1 binding to syntaxin-1, aided by Rab3-interacting molecule (RIM), making it available 
to freely interact with the other SNARE proteins (Rizo and Sudhof, 2002; Sassa et al., 1999). 
Mutations in Munc13-4 cause familial hemophagocytic lymphohistiocytosis 3 (FHL3) in human 
patients (Feldmann et al., 2003). CGs of CTLs isolated from FHL3 patients are able to dock at 
the IS but fail to fuse with the plasma membrane of the CTL, a requirement for killing of the 
target cell, consistent with a priming defect (Feldmann et al., 2003). Munc13-4 is an effector 
protein of Rab27a in mast cells, where it localizes to and regulates the function of secretory 
lysosomes in these cells (Neeft et al., 2005). Munc13-4 was also identified as a binding partner 
of Rab27a in platelets, which mediates the secretion of their dense core granules (Shirakawa et 
al., 2004).  
Rab proteins are small GTPases that are involved in the regulation of vesicle fusion and thus 
SNARE proteins function. Each Rab protein has several effector proteins; it is mainly through 
their effectors that Rab proteins are able to regulate SNARE protein function. Rab3, a regulator 
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of synaptic vesicle fusion, acts with its effector proteins, e.g. RIM (Wang et al., 1997) and 
Rabphilin-3A (Shirataki et al., 1993) probably by regulating the availability of vesicles thereby 
determining their fusion efficiency. Though Rab3 is not expressed in CTLs, the related protein 
Rab27 is present and was shown to be involved in CG fusion in these cells (Menasche et al., 
2000). Mutations in Rab27a lead to a disease known as Griscelli syndrome type II (GS2) 
(Menasche et al., 2000), which might develop to haemophagocytic syndrome (HS), a disease that 
is caused by increased activation of immune cells. CTLs from GS2 patients show reduced killing 
activity and reduced CG exocytosis, however they show no defect in polarization of the granules 
towards the IS (Stinchcombe et al., 2001a).  
I.2.1.3 Fusion  
The SNARE proteins involved in the formation of the SNARE complex are critically important 
for fusion. The zippering of the SNARE proteins proceeds from the N-terminus towards the C-
terminus of each of the SNARE proteins forming a coiled-coil complex (Sorensen et al., 2006), 
which is thought to provide the driving force for vesicle fusion (Sollner et al., 1993b). Zippering 
of the SNARE proteins is triggered by an increase in intracellular calcium concentrations, 
bringing the vesicle membrane and plasma membrane closer together. The transmembrane 
domains of Syb2 and syntaxin are thought to transmit the energy initiated by the SNARE 
complex formation into the phospholipid membranes and induce their deformation thus 
facilitating membrane fusion (Jahn and Scheller, 2006). The membrane embedded region of 
syntaxin lines the fusion pore and its timing and dilation is thought to be regulated by Syb2 (Han 
et al., 2004). After fusion, the vesicle membrane is in continuity with the plasma membrane and 
the SNAREs then form transiently the cis-SNARE complexes before they are disassembled by 
the ATPase NSF (Sollner et al., 1993a). 
I.3 Endocytosis 
Eukaryotic cells have established endocytosis during their evolution to select for molecules 
entering the cell from the sea of molecules in the extracellular medium, rather than by entering 
through channels or pumps as in prokaryotes. Intercellular communication and communication 
between cells and the surrounding environment is initiated by ligands that bind to surface 
receptors to initiate a signaling cascade via activation of receptor-interacting proteins or via 
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endocytosis of the ligand-bound receptor to initiate intracellular signaling. Endocytosis of 
signaling receptors regulates cell activity by controlling the number of receptors available at the 
plasma membrane. The endocytosis of any cargo from the plasma membrane into the cell 
requires a selection mechanism that occurs at the plasma membrane. Many different endocytic 
pathways taken by different cargoes have been found, and they are widely classified as either 
clathrin-mediated endocytosis (CME), including constitutive and ligand-induced endocytosis, or 
clathrin-independent endocytosis (CIE). The latter can be dynamin-dependent or dynamin-
independent in contrast to CME that is always dynamin-dependent. This classification is based 
on the requirement of the endocytosed vesicles for the function of the large GTPase dynamin to 
be pinched-off from the plasma membrane (Le Roy and Wrana, 2005; McMahon and Boucrot, 
2011). 
I.3.1 Clathrin-mediated endocytosis (CME) 
I.3.1.1 Mechanism of clathrin-mediated endocytosis (CME) 
Clathrin-mediated endocytosis (CME) is one of the best-characterized routes of receptor-
mediated endocytosis. CME represents the process of cargo protein recycling from the plasma 
membrane via a clathrin-coated vesicle, with the aid of adaptor proteins, as clathrin, the main 
coat component, forms a scaffold around the vesicle (Figures 4, 6A) (Pearse, 1975). CME 
proceeds through five different stages whereby different sets of proteins are involved at each 
stage (Figure 4) (McMahon and Boucrot, 2011). Stage I, nucleation, is the formation of the 
nucleation module by a group of proteins called FCH domain only (FCHo) proteins, intersectins 
and epidermal growth factor receptor (EGFR) substrate 15 (EPS15) where these proteins define 
the site at the plasma membrane to which clathrin will be recruited. Depletion of any of these 
proteins prevents the formation of the clathrin-coated pit (CCP). The FCHo proteins contain an 
F-BAR domain with membrane-bending activity that then recruits the scaffold proteins 
intersectins and EPS15 (Henne et al., 2010; Stimpson et al., 2009). FCHo proteins also interact 
with Phosphatidylinositol 4,5-bisphosphate (PI(4,5)P2) present at the plasma membrane, which 
in turn interacts with the adaptor protein AP2 at its α subunit N-terminus and μ2 subunit (Collins 
et al., 2002; Rohde et al., 2002). AP2 is the main adaptor protein for CME (Keen, 1987; Pearse 
and Robinson, 1984) and its function is restricted to the plasma membrane (Gaidarov and Keen, 
1999). AP2 initiates the second stage of CME known as cargo selection by binding to the cargo 
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protein directly or indirectly through cargo-specific adaptor proteins. AP2 is one of several AP 
complexes that are composed of several subunits: two large subunits ‘α and β2’ each having a 
core and an appendage domain, a medium subunit (μ2) and a small subunit (σ) (Kirchhausen et 
al., 1989). AP2 binds to its protein cargoes via its μ2 and σ subunits by recognizing certain target 
sequences present on the cargoes; these are short peptide motifs present mainly on integral 
membrane proteins, the most common are the tyrosine-based motif ‘Yxxφ’ (Ohno et al., 1995) 
and the dileucine (D/ExxxLL) motif (Rapoport et al., 1998). ANTH-domain containing brain-
specific AP180 and ubiquitous CALM proteins, found to be responsible for endocytosis of Syb2 
in the central nervous system (CNS), are examples of cargo specific adaptor proteins (Koo et al., 
2011a). Other adaptor proteins like epsin and Dab2 are also involved in specific target 
recognition along with AP2 to which they bind via its appendage domains. Clathrin recruitment 
follows cargo selection i.e. AP2 binding to its cargo and to PI(4,5)P2 at the plasma membrane 
marking the start of the third stage of CME. AP2 interacts with soluble clathrin components via 
defined motifs in the β2 and appendage domains (Owen et al., 2000), which may displace some 
of the other accessory binding adaptor proteins. Clathrin is composed of three heavy chains and 
three light chains that polymerize once they are recruited by AP2 to form a lattice around the 
nascent vesicle forming a clathrin-coated pit (CCP) (Fotin et al., 2004). The pit invagination is 
then deepened to form a vesicle that is still bound to the plasma membrane via its neck. In the 
fourth stage of CME, the large GTPase, dynamin, is recruited to the site of vesicle scission by 
BAR-domain containing proteins via interactions with its proline-rich domain (PRD) and 
pleckstrin homology (PH) domain (Ferguson et al., 2009). Dynamin then polymerizes around the 
nascent vesicle neck, acting as a mechanochemical enzyme, by inducing its pinching off from the 
plasma membrane after GTP hydrolysis (Marks et al., 2001; Sweitzer and Hinshaw, 1998). Many 
reports have shown that inhibiting dynamin function at this stage, by using inhibitors such as 
dynasore (Macia et al., 2006) or by using different dynamin mutants, produces invaginated 
clathrin-coated pits that cannot pinch off to form a vesicle. Dynamins function to cleave the 
clathrin-coated vesicle. This is then followed by the disassembly of the clathrin coat from the 
nascent vesicle, marking the last stage of CME (uncoating), allowing it to fuse with acceptor 
membranes, where the coat components can be recycled for the fission of new vesicles. Several 
proteins are involved in the uncoating process including the ATPase heat shock cognate 70 kDa 
(HSC70) (Schlossman et al., 1984) that is recruited by the neuronal cofactor auxilin 
(Ungewickell et al., 1995) and the abundant cyclin G-associated kinase (GAK) (Umeda et al., 
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2000) which bind to clathrin triskelia initiating clathrin coat disassembly in an ATP-dependent 
manner. The polyphosphoinositide phosphatase synaptojanin 1 might also be involved in clathrin 
coat disassembly (Cremona et al., 1999) as it can bind to accessory adaptor proteins on the 
clathrin-coated vesicle and probably weakens their binding to the vesicle membrane by changing 
its phosphoinositide composition. These cargo-carrying vesicles are now ready to enter the 
endocytic pathway. They sort the cargo, and according to the cell’s need, it is either recycled 
back to the plasma membrane or trafficked to the lysosomes mainly for degradation. 
 
Figure 4. Clathrin-coated vesicle formation.  
a, The five different steps required for clathrin-coated vesicle formation are shown in detail with the proteins 
involved at each step. Nucleation: The FCHo proteins binding to PtdIns(4,5)P2 at the plasma membrane initiate 
nucleation of the plasma membrane as they recruit intersectins and EPS15 proteins and later AP2. Cargo selection: 
The AP2 binds directly to the cargo protein to be endocytosed through its different subunits or indirectly through 
cargo-specific adaptors. Coat assembly: cytosolic clathrin triskelia bind to AP2 bound to its cargo at the plasma 
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membrane and polymerize to form a clathrin coat around the nascent vesicle. Scission: Dynamin, a large GTPase 
protein, is recruited to the forming vesicle where it polymerizes around the vesicle neck to induce budding of the 
vesicle. Uncoating: The ATPase HSC70 is recruited to the newly formed clathrin-coated vesicle by auxilin or GAK 
proteins, where it then starts the ATP-dependent process of uncoating of the vesicle; released proteins can then be 
recycled and used in another round of clathrin-dependent endocytosis. b, A scheme showing the central players 
(shown in big circles) in each of the previously mentioned steps of clathrin-dependent endocytosis along with many 
of their interaction partners. c, Epithelial cells expressing different fusion proteins, FCHo2 tagged with red 
fluorescent protein (RFP), AP2 tagged on the σ2 subunit with enhanced green fluorescent protein (σ2–eGFP) and 
clathrin tagged with blue fluorescent protein (BFP), are silenced for any of these proteins using siRNA against the 
protein shown on the top of the image. These experiments show the requirement of the transfected proteins for 
clathrin-coated vesicle formation in the sequence shown in (a). AAK, AP2-associated protein kinase 1; AP2, adaptor 
protein 2; ARP2/3, actin-related protein 2/3; DAB2, Disabled homologue 2; EPS15, EGFR  substrate 15; FCHo, 
FCH domain only; GAK, G-associated kinase; HSC70, heat shock cognate 70; HIP1R, HIP1-related; N-WASP, 
neural Wiskott-Aldrich syndrome protein; NECAP, adaptin ear-binding coat-associated protein; PtdIns(4,5)P2, 
phosphatidylinositol(4,5)bisphosphate; SNX9, sorting nexin 9 (McMahon and Boucrot, 2011). 
I.3.1.2 Constitutive versus ligand-induced CME 
CME can be divided into constitutive and ligand-induced endocytosis. The constitutive pathway 
is mainly taken by non-signaling receptors as for the case of the ones involved in nutrient uptake 
such as transferrin-R (Watts, 1985) and LDL-R (Anderson et al., 1982). These receptors are 
continuously endocytosed and are then sorted in the endosomal pathway to be either transported 
back to the cell surface or to lysosomes for degradation. 
In ligand-induced endocytosis, ligand binding induces the activation of the bound receptors, 
which induces their internalization, typically to lysosomes for degradation, and terminates their 
response. This is typical of signaling receptors like epidermal growth factor receptor (EGF-R) 
(Beguinot et al., 1984) and other receptor tyrosine kinases (RTKs). This process of endocytosis 
serves to remodel the plasma membrane protein composition and to relocalize specific receptors 
to certain membrane areas important for signaling. 
I.3.2 Clathrin-independent endocytosis (CIE) 
Endocytosis can be further classified according to the type of the vesicle a protein is incorporated 
into upon endocytosis (Le Roy and Wrana, 2005). Although the best-characterized mode of entry 
is clathrin-mediated endocytosis (CME), clathrin-independent endocytic (CIE) pathways exist as 
well. CIE is regulated differently from CME that allows for a wider regulatory spectrum of the 
cell’s functional activities. There are several forms of CIE, requiring different proteins such as 
caveolin, flotillin, and ADP-ribosylation factor (ARF). Many different aspects of CIE still needs 
to be investigated. The mechanism of cargo selection in CIE can be protein-dependent, lipid-
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dependent or both protein and lipid dependent. CIE can be further classified as dynamin-
dependent and dynamin-independent, as it has been shown that dynamin is not restricted to CME 
pathways. 
I.3.2.1 Dynamin-dependent CIE 
Caveolae-mediated endocytosis is one of the best-characterized dynamin-dependent CIE 
pathways. A member of the caveolin (Cav) protein family marks a small region of the plasma 
membrane (50-80 nm), enriched in sphingolipids and cholesterol (Simons and Ikonen, 1997) 
(Nabi and Le, 2003), to be endocytosed into the cytosol as caveolae with a flask-shaped structure 
(Parton and Simons, 2007). Another dynamin-dependent CI pathway is known as RhoA-
dependent pathway, initially discovered for the β-chain of the IL-2R, this pathway can also be 
used by other different proteins (Lamaze et al., 2001). Although endophilin is known to be 
involved in CME, it has been shown to be involved in dynamin-dependent CIE named fast 
endophilin-mediated endocytosis (FEME) (Boucrot et al., 2015). FEME produces 
tubulovesicular invaginations of the plasma membrane and is activated by ligand binding 
(activated within seconds of ligand binding), where it mediates the endocytosis of several G-
protein-coupled receptors (GPCRs) and protein tyrosine kinases (Boucrot et al., 2015). 
I.3.2.2 Dynamin-independent CIE 
Dynamin-independent CIE has also been described. A fluid-phase uptake that is increased upon 
expressing dynamin-I mutant (Damke et al., 1995) or the temperature sensitive-form of dynamin 
(shibire) (Guha et al., 2003) involve ARF6 and CDC42 small GTPases. The latter is required for 
the uptake of cholera toxin B (CtxB) (Llorente et al., 1998) and ARF6 is required for the uptake 
of MHC class I (Radhakrishna and Donaldson, 1997) among other proteins (Kumari and Mayor, 
2008). Another CI mechanism, mediated by lipid-raft associated proteins flotillin 1 and 
flotillin 2, is mediated by dynamin-dependent pathways for some proteoglycans (Ait-Slimane et 
al., 2009) and dynamin-independent pathways for certain glycosylphosphatidylinisotol (GPI) 
anchored proteins (Glebov et al., 2006). 
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I.4 The endosomal pathway: from the plasma membrane to the endosomal 
system 
I.4.1 Rab proteins binding to membranes 
Rab proteins, involved in vesicle transport regulation (to and from the plasma membrane and 
between organelles) and determining organelle identity, constitute the largest family of the small 
GTPases, with about 63 different members in humans compared to only 11 members in 
Saccharomyces cerevisiae. The higher number of Rab proteins in humans reflect their 
requirement for the regulation of the more sophisticated transport systems in higher organisms 
(Zerial and McBride, 2001). GTP-bound ‘active’ Rab proteins bind membranes by means of a 
geranylgeranyl group added to the two consensus cysteines at their C-termini; upon GTP 
hydrolysis to GDP the GDP-bound ‘inactive’ Rab proteins are released from membranes. Rab 
Escort Protein (REB) presents the soluble Rab to an enzyme called Rab geranylgeranyl 
transferase (RabGGT) that transfers the geranylgeranyl group to the Rab protein allowing it to 
bind membrane. Guanine nucleotide exchange factors (GEFs) catalyze the exchange of GDP to 
GTP by interacting with specific amino acids of the Rab protein (Delprato et al., 2004). GTP is 
then hydrolyzed not only by the intrinsic GTPase activity of the Rab protein, but also by certain 
proteins called GTPase-activating proteins (Figure 5) (GAPs) (Haas et al., 2007).  
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I.4.2 Acidification of endosomes 
Endosomes are characterized by a mildly acidic pH that gradually decreases as a cargo is 
traversed through the endocytic pathway. This acidic pH is maintained by an ATP-driven proton 
pump, the V-type H+ ATPase (where V stands for vacuolar) [reviewed in (Beyenbach and 
Wieczorek, 2006)]. The V-ATPase constitutes a large complex composed of 2 domains, the 
cytosolic V1 domain that undergoes ATP hydrolysis and the V0 domain an integral membrane 
protein that functions in proton translocation. Each of the two domains consists of different 
subunits, with 8 subunits making up V1 and 5 subunits for V0. Regulation of the V-ATPase 
function is mainly attributed to the reversible association and dissociation of the two domains 
(Forgac, 1998; Lafourcade et al., 2008; Trombetta et al., 2003). The endosomal pH helps, for 
example, to dissociate ligands from signaling receptors and thus prevents excessive signaling 
from these ligand-bound receptors. Ligands and receptors can then be sorted into different 
compartments in the sorting endosome to be further processed. 
Figure 5. Rab proteins binding to 
and release from membranes.  
(a) GDP-bound prenylated Rab 
proteins bind to GDI in the cytosol 
and are directed towards their target 
membrane. There, resident GDF 
catalyzes the attachment of Rab 
GTPase to the membrane. GEF 
proteins convert GDP-bound Rab to 
GTP-bound once they are bound to 
the membrane, where they can then 
interact with their effector protein. 
(b) After catalysis of the GTP to 
GDP, the GDP-bound Rab GTPase 
can be retrieved again by GDI 
protein. Hsp90 is thought to be 
involved in this interaction in 
neuronal cells. GDI, GDP-
dissociation inhibitor; GDF, GDI-
displacement factor; GEF, guanine-
nucleotide exchange factor (Pfeffer 
and Aivazian, 2004). 
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I.4.3 From the plasma membrane to the early endosomes and back 
Routing through the endocytic pathway has been studied in great detail for many proteins. 
Generally the first stop for an endocytic vesicle using any pathway for entry into the cell is at the 
early endosomes (EEs) also known as sorting endosomes (Figure 6B) (Yamashiro and Maxfield, 
1987). Serving as a focal point for endocytosed vesicles (Mayor et al., 1993), EEs are 
characterized by a slightly acidic pH (pH 6.5) (Maxfield and McGraw, 2004; Yamashiro et al., 
1984) that allows for the dissociation of ligands bound to receptors as in the case of signaling-
receptors’ endocytosis. Rab5 a small GTPase and its main effector early endosomal antigen 1 
(EEA1) mark the early endosomes; they are required for the transport and fusion of vesicles with 
EEs and for sorting proteins to their different fates (Bucci et al., 1992; Christoforidis et al., 
1999). Rab5 availability is maintained on EEs by the GTP/GDP cycle of the GTPase and also by 
the continual homotypic fusion events between different Rab5-positive endosomes (Rink et al., 
2005). Early endosomes show a pleomorphic structure with different tubular and vesicular 
structures, protein composition and probably different acidity that might also imply differential 
functions of sorting proteins either to recycling pathway or to degradative pathway (Gruenberg, 
2001; Mellman, 1996; Raiborg et al., 2002). Ligands of signaling receptors are usually sorted to 
the degradative pathway whereas their receptors can be used for several rounds of recycling 
before being degraded (Basu et al., 1981; Fehlmann et al., 1982). For example, epidermal growth 
factor (EGF) dissociates from its receptor (EGFR) once they reach the EEs, where both can be 
trafficked further to be degraded in the late endosomes, or EGF can be degraded while the EGFR 
is recycled back to the plasma membrane through recycling endosomes for another round of 
signaling [reviewed in (Tomas et al., 2014)]. The transferrin receptor, the classical endocytic 
receptor for recycling to the plasma membrane, is endocytosed upon binding of its ligand as 
diferric transferrin (transferrin with two bound atoms of ferric iron (Fe3+)). After uncoating of the 
clathrin-coated vesicles carrying the transferrin-transferrin receptor complex, they can fuse with 
two different populations of EEs. In the acidic environment of the EEs, ferric ions are dissociated 
from transferrin though it remains bound to its receptor. From the EEs the complex is then either 
recycled in a Rab4-dependent fast route directly to the plasma membrane (2.5 minute) or through 
a Rab4/Rab11-dependent slower route via the recycling endosomes (7.5 minute) (Hopkins and 
Trowbridge, 1983; Sonnichsen et al., 2000; Stein and Sussman, 1986). Rab11 interacts with 
Myosin Vb via Rab11 family interacting protein 2 which regulates protein recycling from the 
plasma membrane (Hales et al., 2002). 
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I.4.4 From the early endosomes to late endosomes 
After sorting into EEs from the plasma membrane, proteins may be further trafficked into Rab7-
containing late endosomes (LEs) for further processing, depending on the cargo protein 
(Figure 6B) (Schmid et al., 1988). LEs are derived from the vesicular domains of EEs, where 
most of the proteins destined for degradation have accumulated; in this region Rab5 is gradually 
lost probably by converting to the GDP-bound form and is then replaced by Rab7 which 
accumulates in this region to generate LEs (Rink et al., 2005). As mentioned before, the pH 
drops further in LEs to values below 6. This might be because the V1 domain of the V-ATPase 
associates more readily with the V0 domain localized to LE membrane thereby forming more 
functional pumps at this site (Lafourcade et al., 2008). It is also thought that the V-ATPases are 
localized to the vesicular regions of EEs, so when these regions transform to LEs, the V-
ATPases are then more concentrated which might contribute to the lower acidity of LEs (Huotari 
and Helenius, 2011). This decrease in the pH in LEs is required for the inactivation of 
internalized pathogens, for proper sorting of certain cargo proteins and for regulating the activity 
of hydrolytic enzymes. Rab7 regulates transport between late endosomes and lysosomes by 
interacting with Rab-interacting lysosomal protein (RILP) which results in recruitment of the 
dynein-dynactin motor complex (Jordens et al., 2001). Further maturation of LEs result in fusion 
of these organelles with lysosomes. This is considered to be a dead-end pathway for most 
proteins where they are degraded by the function of lysosomal enzymes. The fusion between LE 
and lysosomes generates ‘endolysosome’ where most of protein degradation takes place; these 
organelles differ from conventional lysosomes, which contain a characteristic dense core 
(Huotari and Helenius, 2011).  
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Figure 6. Sorting of endocytosed vesicle components through the endocytic pathway.  
A, A clathrin-coated vesicle carrying cargo-bound receptors with the adaptor proteins mainly AP2. Dynamin 
surrounds the vesicle neck, as it is ready to be pinched off. B, A general scheme of the pathway followed by a 
vesicle following endocytosis, whether by clathrin-dependent, clathrin-independent or caveolae-dependent 
mechanism. Most endocytosed vesicles fuse first with the early endosomes (sorting endosomes, Rab5-positive 
endosomes), from where they are either recycled back to the plasma membrane by recycling endosomes (Rab11-
positive endosomes) or trafficked further to late endosomes (Rab7-positive endosomes) through multivesicular 
bodies and then to lysosomes (Le Borgne et al., 2005). 
I.5 Immune diseases associated with the SNARE machinery dysfunction 
The main function of CTLs is to kill virally-infected and tumor cells by releasing cytotoxic 
proteins to be endocytosed by target cells inducing their death. Malfunction in the exocytosis of 
cytotoxic granules (CGs) leads to the inability to kill target cells. Several human diseases caused 
by mutations in proteins associated with the SNARE fusion machinery have been described. 
Familial hemophagocytic lymphohistiocytosis (FHL) is an immune disorder caused by mutation 
of genes involved in the lysosomal secretory pathway. FHL is classified into different types 
depending on the corresponding mutated gene, PRF1 gene in FHL2 (Stepp et al., 1999), 
Munc13-4 gene in FHL3 (Feldmann et al., 2003), STX11 in FHL4 (zur Stadt et al., 2005) and 
Munc18-2 in FHL5 (Cote et al., 2009). FHL patients present with symptoms related to 
hyperactivation of immune cells (such as macrophages and T cells) which is probably due to the 
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cells’ inability to clear infections (Sieni et al., 2014). Symptoms also include 
hepatosplenomegaly, fever, bone marrow hemophagocytosis and neurological abnormalities. 
FHL usually shows early onset in life and if left untreated, it is usually fatal (Sieni et al., 2014). 
Griscelli syndrome 2 (GS2) caused by mutations in the small GTPase Rab27a (Menasche et al., 
2000) is also associated with defects in cytotoxic granule secretion. GS2 patients show 
hypopigmentation and immune abnormalities (hemophagocytosis) due to defects in melanosome 
exocytosis from melanocytes and CG granules from CTLs, respectively (Menasche et al., 2000). 
Rab27a is expressed in lymphocytes and melanocytes explaining the defects present with GS2 
(Chen et al., 1997). Mice lacking Rab27a, known as ashen mice, also present with reduced 
killing activity of their CTLs, but do not develop hemophagocytosis. Chediak-Higashi syndrome 
(CHS) is an autosomal recessive disease caused by mutations in lysosomal trafficking regulator 
protein (LYST) (Barbosa et al., 1996), which manifests with albinism and a lymphocyte killing-
dysfunction. The normally produced lysosomes fuse to form giant organelles but are not able to 
fuse with the plasma membrane (Baetz et al., 1995).  
In addition to these diseases caused by the inability of granule exocytosis, several other immune 
disorders are associated with deficiency of endocytosis of components required for the fusion 
machinery (Mosesson et al., 2008), resulting in their exhaustion and a loss of exocytotic 
function. Understanding the mechanism of endocytosis of the different proteins involved in the 
fusion machinery would thus give us insight into their mechanism of action and disturbances 
leading to disease.  
I.6 Synaptobrevin2 (Syb2) 
Synaptobrevin2 (Syb2) is a component of the SNARE complex involved in CG fusion. Syb2, 
also known as VAMP2, for vesicle associated membrane protein 2, was discovered in the late 
1980’s (Baumert et al., 1989) as a protein component of synaptic vesicles (SVs). Shortly 
afterwards, Syb2, was shown to be the target for tetanus toxin and some botulinum toxin 
subtypes (Link et al., 1992) (Schiavo et al., 1992). Since these toxins are specific blockers of 
synaptic transmission, Syb2 was considered to be a critical player in SV fusion. 
Syb2 binds to the vesicle membrane via a C-terminal hydrophobic domain. An adjacent linker 
joins the transmembrane domain (TMD) with the SNARE motif and a short proline-rich N-
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terminal sequence (Archer et al., 1990; Fasshauer et al., 1998). Syb2 is the most abundant protein 
of synaptic vesicles (Takamori et al., 2006). When a vesicle undergoes exocytosis, its membrane 
becomes a part of the plasma membrane. In order to prevent excessive increase in the plasma 
membrane surface area and to compensate for loss of synaptic vesicles and their components, 
vesicles are recycled via endocytosis. The mechanism of endocytosis at synapses has been 
investigated in neurons where it is mainly clathrin-dependent (Granseth et al., 2006). Despite 
extensive studies on endocytosis of synaptic vesicle (SV) membrane, the mechanism of SV 
membrane retrieval remains controversial. Depending of the strength of the stimuli, different 
modes of endocytosis may be used (Kononenko and Haucke, 2015). The main models for 
endocytosis at synapses include the retrieval of SV membrane by CME directly after fusion, or 
the formation of clathrin-coated SVs from an endosome-like vacuole (ELV), that is formed in a 
clathrin-independent ultra-fast endocytosis (Watanabe et al., 2014). 
AP180, a brain specific adaptor protein and its homologue the more ubiquitous adaptor protein 
clathrin assembly lymphoid myeloid leukemia (CALM), were identified as adaptor proteins 
specific for the endocytosis of Syb2 (Koo et al., 2011a). Syb2 was shown to interact directly with 
the ANTH domain of AP180 and CALM adaptor proteins at the N-terminal half of its SNARE 
motif, which is probably important for the retrieval of free Syb2 that has dissociated from its 
SNARE partners (Koo et al., 2011a; Koo et al., 2011b). 
Syb2 has been shown to be expressed in several types of immune cells and to regulate the fusion 
of different types of vesicles in these cells. For example, in neutrophils, Syb2 migrates to the 
plasma membrane upon activation of these cells (Brumell et al., 1995). Syb2 is also expressed in 
macrophages (Pitzurra et al., 1996) and eosinophils (Shukla et al., 2000), where cleaving Syb2 
inhibits degranulation. Matti et al found that Syb2 is the v-SNARE required for fusion of CGs of 
mouse CTLs (Matti et al., 2013). Given the Syb2 expression in immune cells and its involvement 
in exocytosis of different types of vesicles, we need to learn more about its endocytosis in these 
cells. Studying the endocytosis of Syb2 in CTLs would not only allow for the description of the 
endocytic pathway of Syb2, but it would also give us insight into the mechanism of CG 
endocytosis in CTLs. 
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I.7 Aim of this work 
Little is known about the endocytosis of CG components in CTLs. Trafficking of molecules to 
and from the plasma membrane is critical for the proper functioning of cells, indicating the 
importance of understanding the mechanism of endocytosis involving critical components such 
as the CGs of CTLs. 
In neurons, different endocytic pathways have been described with ultrafast and slow 
endocytosis (ranging from milliseconds to seconds) involving different proteins with different 
mechanisms of endocytosis; either the synaptic vesicle is endocytosed directly without diffusing 
with the plasma membrane, or the synaptic vesicle components are endocytosed individually or 
in case of excessive stimulus, bulk endocytosis takes place. The latter allows for a large area of 
the plasma membrane to be endocytosed forming an endosome-like vacuole (ELV), where 
clathrin-coated vesicles would bud from it inside the cytosol. 
The work presented here investigates the mechanism of CG endocytosis via the trafficking of CG 
membrane components in mouse CTLs following exocytosis. Syb2 endocytosis has been shown 
to be critical for the serial killing function of CTLs (Chang et al., 2016). Syb2, the v-SNARE 
required for fusion of CGs (Matti et al., 2013), is therefore used as a marker to follow the 
endocytic pathway of CG membrane components. CTLs from sybki (Syb2-mRFP knock-in) 
mice were utilized in our study to follow the fluorescently-labelled Syb2 using a specific anti-
RFP antibody. Studying the endocytosis of CG membrane components will give us insight into 
the efficacy of CTL function such as the ability to kill multiple target cells. 
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II. Materials and Methods 
II.1 Materials: 
II.1.1 Chemicals 
Product Company 
Agar Roth 
BSA Sigma-Aldrich 
β-Mercaptoethanol Roth 
Chloroform Sigma-Aldrich 
cOmplete Mini, EDTA-free Protease Inhibitor Cocktail Tablets Roche 
Dithiothreitol Sigma-Aldrich 
dNTP-Mix Fermentas 
DPBS Life Technologies 
Ethanol 100% Roth 
EtBr Life Technologies 
EDTA Sigma-Aldrich 
EGTA Sigma-Aldrich 
FCS Life Technologies 
Formaldehyde PolyScience 
Glucose Merck 
Glutamax Life Technologies 
Glycerol Roth 
Glycine Roth 
HEPES Sigma-Aldrich 
HPLC water Life Technologies 
IMDM Thermo Scientific 
Isopropanol Roth 
Kanamycin K-1377 Sigma-Aldrich 
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Product Company 
KCl Merck 
λ Marker Roche 
Methanol 100% Roth 
MgATP Sigma-Aldrich 
NaCl Merck 
NaCHO3 Merck 
Nonfat dried milk powder AppliChem Panreac 
NuPAGE 10% Bis-Tris Gel 1.0mm Fisher Scientific 
NuPAGE LDS sample buffer 4x Invitrogen 
NuPAGE MES SDS Running Buffer 20x Fisher Scientific 
NuPAGE Transfer Buffer 20x Fisher Scientific 
PCR-buffer Sigma-Aldrich 
Pen/strep Gibco 
Peptone Roth 
pfu-Polymerase Buffer Fermentas 
Phenol Sigma-Aldrich 
Polyornithine Sigma-Aldrich 
Ponceau S solution 0,1% Sigma-Aldrich 
Protein G Agarose Thermo Scientific 
Protran BA 83 Nitrocellulose Membrane Fisher Scientific 
Restore Western Blot Stripping Reagent Fisher Scientific 
RPMI Sigma-Aldrich 
Roti Nanoquant 5x Roth 
Spectra Multicolor Broad Range LAD Fisher Scientific 
Streptomycin Life Technologies 
Sucrose Merck 
Super Signal West Dura Extended Fisher Scientific 
Triton X-100 Roth 
Tris-hydrochloride Roth 
TRIzol Life Technologies 
Tween 20 Roth 
Water Sigma-Aldrich 
MATERIALS AND METHODS 
 
39 
 
II.1.2 Solutions for cell culture 
II.1.2.1 RPMI 1640 (10% FCS) 
RPMI, 500 ml  
FCS, 50 ml, (10%) 
Pen/Strep, 5.5 ml, (1%) 
Hepes from 1 M stock, 5.5 ml, (10 mM) 
II.1.2.2 IMDM (10% FCS) 
IMDM, 500 ml  
FCS, 50 ml, (10%) 
Pen/Strep, 2.75 ml, (0.5%) 
β-mercaptoethanol, 1.936 μl, (50 μM) 
II.1.2.3 Isolation Buffer 
PBS, 500 ml  
BSA, 0.5 g, (0.1%) 
EDTA from 0.5 M stock solution, 2 ml, (2 mM)  
II.1.2.4 Erythrolysis buffer (100 ml) 
H2O, 100 ml 
NH4Cl, 0.829 g, (155 mM) 
KHCO3, 0.1 g, (10 mM) 
EDTA from 50 mM stock, 260 μl, pH 7.4 (0.1 mM) 
II.1.3 Solutions for cell fixation and staining 
II.1.3.1 Paraformaldehyde (15% PFA, 10 ml) 
PFA, 1.5 g 
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Sigma H2O, 10 ml 
NaOH, 20 µl 
pH 7.4 
II.1.3.2 Quenching Solution (0.1 M Glycine) 
Glycine, 0.375 g 
PBS, 50 ml 
II.1.3.3 Permeabilization Solution (50 ml, 0.1% Triton) 
Triton x-100, 50 µl 
PBS 1x, 50 ml 
II.1.3.4 Blocking Solution (50 ml, 2% BSA) 
BSA, 1 g  
Triton x-100, 50 µl 
PBS, 50 ml 
II.1.3.5 Mounting Medium 
Mowiol 4-88, 2.4 g 
Glycerol, 6 g 
H2O double distilled, 6 ml 
Tris-Buffer, 12 ml 
pH 8.5 
II.1.4 Solutions for cloning  
II.1.4.1 LB-Medium 
Peptone, 8g 
Yeast extract, 4g 
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NaCl, 4 g 
H2O, 800 ml 
II.1.4.2 Loading Buffer 
Sucrose, 4g 
Bromophenol blue 
Sigma H2O, 10 ml 
II.1.5 Solutions for Western blot 
II.1.5.1 Lysis buffer (5 ml) 
Tris-Cl, 50 mM 
NaCl, 150 mM 
PMSF, 250 µM 
Triton x-100, 1% 
Deoxycholic acid, 1 mM 
EDTA, 1 mM 
DTT, 1 mM 
H2O, up to 5 ml 
1 tablet protease inhibitor cocktail 
II.1.5.2 TBS (10x) 
NaCl, 87.7 g 
1 M Tris-Cl (pH 7.5), 100 ml 
H2O, up to 1 L 
II.1.5.3 TBST (0.05%) (1L) 
10x TBS, 100 ml 
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Tween 20, 500 µl 
H2O, 900 ml 
II.1.6 Bacteria and Cell Lines 
II.1.6.1 Bacteria 
DH5α: F– endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG purB20 φ80dlacZΔM15 
Δ(lacZYA-argF) U169, hsdR17(rK–mK+), λ–. Invitrogen, Life Technologies 
II.1.6.2 Cell Lines 
P815 cell line from DSMZ. DSMZ no. ACC 1 
II.1.7 Mouse Strains 
C57Bl/6N (Black 6), Stock No: 005304, The Jackson Laboratory 
Synaptobrevin2-mRFP knock-in mouse (sybki) (Matti et al., 2013)  
II.1.8 Kits 
II.1.8.1 Kits for cloning 
EndoFree Plasmid Maxi Kit, Qiagen 
EndoFree Plasmid Mini Kit, Qiagen 
QIAprep Spin Miniprep Kit, Qiagen 
QIAquick Gel Extraction Kit, Qiagen 
QIAquick PCR Purification Kit, Qiagen 
II.1.8.2 Kits for cell culture 
Dynabeads FlowComp mouse CD8 kit, Thermo Fisher 
Dynabeads mouse T-activator CD3/CD28 for T-cell expansion and activation, Thermo Fisher 
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II.1.9 Antibodies 
Antibody for STX11 has been produced in our lab earlier (Halimani et al., 2014). Antibody 
against a3 subunit of the H+ V-ATPase was a kind gift from Prof. Thomas Jentsch (FMP, berlin). 
Antibodies used from commercial sources include anti-CALM antibody (sc-6433; Santa Cruz), 
hamster anti-mouse CD3e antibody (clone 145-2C11; BD Pharmingen), anti-granzyme B 
antibody (4275S, Cell Signaling), mouse anti-Syb2 antibody (104211, clone 69.1; synaptic 
systems), rabbit anti-RFP antibody (Genway Biotech), rabbit anti-SNAP-23 antibody (111203; 
synaptic systems), anti-ZAP70 antibody (clone 1E7.2; Merck Millipore) and all AlexaFluor 
secondary IgG antibodies (Invitrogen). The anti-RFP antibody was labeled with the different 
Alexa fluorophores (Alexa405, 488 and 647) and pHrodo green STP ester (ThermoFischer 
Scientific) using a commercially available mAb labeling kit from Invitrogen. 
II.1.10 Plasmids 
II.1.10.1 Plasmids for Rab proteins 
Plasmids for eGFP-Rab5/7/11 have been previously described (Halimani et al., 2014). Briefly, 
each Rab protein was amplified with a primer that had BamHI and EcoRI restriction sites at both 
ends, where the PCR product was then ligated to a vector already containing eGFP-C1 to the N-
terminus of the Rab protein. 
II.1.10.2 pMAX with a new multiple cloning site (MCS): 
‘pMAX-minus eGFP’ was used as a template to generate a new pMAX vector with an improved 
multiple cloning site (MCS). The vector was cut with KpnI and NheI to introduce the new MCS 
sequence consisting of the following restriction sites KpnI-ClaI-EcoRI-HindIII-XbaI-BglII-
BamHI-NotI-NheI, with overhangs for KpnI and NheI (ClaI is also known as Bsu15I, shown in 
the map). The sequence of the two oligonucleotides was as follows, Positive strand:  
5’ CATCGATGAATTCAAGCTTCTAGAGATCTGGATCCGCCGCGGCCGCG 3’  
Negative strand:   
5’ CATGGTAGCTACTTAAGTTCGAAGATCTCTAGACCTAGGCGGCGCCGGCGCGATC 3’  
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The two oligonucleotides were ordered with a 5’-phosphate modification on each strand. Before 
ligation into the pMAX the two oligonucleotides were hybridized; 2 µg from each oligo were 
mixed together in an eppendorf, then water was added to make a final volume of 50 µl. The 
eppendorf was put in a beaker containing boiling water for 2-3 minutes. Then, the whole beaker 
was put in an empty icebox, covered with a lid to allow the temperature to decrease slowly. The 
oligonucleotides were kept for 3.5 hrs in the icebox. The measured DNA concentration was 150 
ng/µl; 10 ng were used for the ligation reaction with 190 ng from the pMAX vector cut with 
KpnI and NheI. Ligation was done overnight at room temperature. Then the ligation product was 
transformed into DH5a bacteria. Positive clones were checked by digestion with HindIII, as 
HindIII is not present in the original vector. Thus, if the MCS is inserted into the vector then 
HindIII should linearize the vector; otherwise the vector shouldn’t be cut. All clones checked 
contained the HindIII restriction site and thus the new MCS. Clones 5 and 6 shown in figure 7A 
were taken for sequencing and further for Maxiprep after checking the sequence. 
The pMAX vector was fully sequenced using the following three primers,  
1. 5’ GGCTATTGGCCATTGCATACG 3’ 
2. 5’ GGACAAACCACAACTAGAATGC 3’ 
3. 5’ GAAGAACTCGTCAAGAAGGCG 3’ 
The sequencing showed that the insert was correctly inserted into the vector. The exceptionally 
small size of the pMAX (2848 bp) vector along with the new inserted MCS (Figure 7B), allowed 
for pMAX to be used as a vector for most of the future cloning in the lab. 
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Figure 7. pMAX vector with the new MCS.  
A, clones of pMAX with the new MCS, digested with HindIII and run on an agarose gel. The gel shows a single 
band for all the clones indicating a linearized vector. Numbers on top of the gel indicate the clone number; M, 
marker. B, vector map of the pMAX showing the new restriction sites added (only single cutter endonucleases are 
shown). Map was done with SnapGene Viewer. 
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II.2 Methods 
II.2.1 Positive isolation of CD8+ T lymphocytes 
The spleen was isolated from 8-12 week old mice, smashed on a 70 μm filter; splenocytes were 
collected in a falcon tube and centrifuged. The erythrocytes were next lysed with an erythrolysis 
buffer. Splenocytes were again washed with RPMI medium. CD8+ T lymphocytes were then 
positively isolated from the splenocytes using ‘Dynabeads FlowComp Mouse CD8’ kit 
according to the manufacturer's instructions. Briefly, 50*106 splenocytes were resuspended in 
500 μl isolation buffer (see Materials and Methods), with 25 μl anti-CD8 antibody provided in 
the kit. Cells were kept on ice for 10 min, and then washed to remove unbound antibody by 
centrifuging cells at 350 *g for 8 min. The pellet was resuspended in 1 ml isolation buffer and 
75 μl of FlowComp Dynabeads were added (provided in the kit). The suspension was incubated 
for 15 minutes while rotating at 4 °C. The cells were then exposed to the magnet for about 2 
minutes, to separate bead-bound cells from free cells. The latter were removed and the bead-
bound cells were washed with isolation buffer and put in the magnet for another 2 minutes. The 
washed bead-bound cells were resuspended in 1 ml release buffer provided in the kit for 10 min 
rotation at RT. Afterwards the cells were exposed to the magnet for 2 minutes, cells were then 
collected by centrifugation at 350 *g for 8 min. CD8+ T lymphocytes were resuspended in 
IMDM medium at a concentration of 106 cells per ml, then plated in a 24-well plate with mouse 
T cell-Activator CD3/CD28 Dynabeads at a ratio of 1:0.8 per well. 
II.2.2 RNA extraction  
Cytotoxic T lymphocytes (CTLs) (5*106 cells) were washed with PBS and resuspended in 1 ml 
trizol. Isolation proceeded as recommended by the manufacturer’s protocol. Briefly, cells were 
lysed by sonication and kept on ice. Cells were centrifuged at 12000 *g for 10 min at 4 °C, and 
the supernatant was transferred to a new eppendorf tube. 200 μl chloroform (per 1 ml trizol) were 
added to the supernatant, mixed and incubated for 2-3 minutes at RT and centrifuged at 12000 *g 
for 15 min at 4 °C.  Different phases appear at this step; the top aqueous phase (which contains 
the RNA) was carefully transferred to a fresh tube. In order to precipitate the RNA, 500 μl 
isopropanol (per 1 ml trizol) were added and incubated for 10 minutes at RT, the sample was 
then centrifuged again at 12000 *g for 10 min at 4 °C. After discarding the supernatant, the RNA 
pellet was washed with 1 ml 70% ethanol (per 1 ml trizol) then centrifuged at 7500 *g for 5 min 
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at 4 °C. Then the supernatant was discarded and the RNA pellet was allowed to air-dry at RT; 
color should change from white to transparent. The pellet was then dissolved in 30 μl DEPC-
treated H2O. 
II.2.3 RNA quality check  
In order to determine the integrity of the RNA, the optical density of the samples was measured 
using an Eppendorf Biophotometer plus. Samples were diluted with RNase-free water, and 
absorbance was measured at 260/280 nm. Reading between 1.8 and 2.0 indicates high quality of 
the RNA. Running the RNA samples on an agarose gel can also determine whether the RNA is 
degraded or not. Figure 8 shows two bands corresponding to the different subunits of the 
ribosomal RNA (28S and 18S) that confirms the integrity of the RNA. 
 
 
 
 
 
 
II.2.4 cDNA synthesis 
cDNA (complementary DNA) synthesis kit was used to synthesize cDNA from RNA isolated 
from activated CTLs by reverse transcription. First 1 μl total RNA (from 1 μg/μl sample), 1 μl 
random primers (1 μM) and 1 μl dNTPs (10 mM) were mixed and kept for 5 minutes at 65 °C in 
order to linearize the RNA secondary structures. Then 4 μl first strand buffer (5x), 1 μl 
RNaseOUT (RNase inhibitor), 2 μl DTT (0.1 M stock) and 1 μl SuperScript II reverse 
transcriptase were added to the mixture and incubated for 1 hr at 42 °C.  
II.2.5 Brain and CTL protein lysate preparation 
Whole brain was isolated from adult mice (8-12 weeks old). Brain was homogenized in protein 
lysis buffer (see Materials and methods). Homogenate was then centrifuged twice at 1000 *g for 
5 minutes at 4 °C to pellet unlysed tissue and cellular debris. The supernatant was then collected, 
Figure 8. RNA quality 
check on an agarose gel. 
Two different RNA samples 
from two different mice are 
run on a gel to check for the 
quality of the RNA. 
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aliquoted, snap-frozen in liquid nitrogen and then stored at -80 °C. An aliquot was taken to 
measure protein concentration using Eppendorf Biophotometer plus. About 10*106 CTLs were 
lysed in lysis buffer (100 μl for 107 cells). Cells were then incubated for 30 min on a shaker at 
4 °C. Then cells were centrifuged at 10,000 *g for 10 min at 4 °C. The supernatant was 
collected, and protein concentration was measured. The lysate was aliquoted, snap-frozen and 
stored at -80 °C until use. 
II.2.6 Western blot 
In order to check the expression of several proteins, CTL protein lysate was used for Western 
blot. First, a reducing agent (β-mercaptoethanol) was added to the 4x LDS sample buffer at a 
10% ratio. The LDS sample buffer was then added to the desired concentration of protein lysate 
at a final ratio of 1x, water was added, if necessary, to a final volume of 35 μl if using a 10-well 
polyacrylamide gel. The prepared samples were then boiled at 99 °C for 5 min and then were 
loaded onto the gel. Pre-cast gels from Invitrogen were used (10% bis-tris polyacrylamide gels). 
MES running buffer (20x) was diluted with distilled water to obtain 1x running buffer. The wells 
of the gel were first washed with the running buffer, and then samples were loaded. Running was 
done at 120 V for 1:30 or 2 hrs depending on the proteins to be detected. Buffer for transfer was 
diluted to 1x from a 20x solution obtained from Invitrogen; methanol was also added to the 
transfer buffer at a final concentration of 20%. After running, the gel was transferred to a 
nitrocellulose membrane soaked in 1x transfer buffer. The transfer was done for 2 hrs at RT at 
200 mA. The membrane was incubated for about a minute with Ponceau S solution to check for 
the quality of the transfer. The membrane was washed with TBST (0.05% tween) for 2 times, 5 
minutes each (to wash out the Ponceau S staining) and then blocked with 5% nonfat dry milk for 
2 hrs at RT. Afterwards the membrane was incubated with the primary antibody for 1 hr at RT or 
overnight at 4 °C, depending on the antibody used. The blot was then washed for 5 times, 5 
minutes each. The secondary antibody coupled to HRP (horseradish peroxidase) was added 
(dependent on the species used to generate the primary antibody; mouse, rabbit, goat…) for 1 hr 
at RT. The blot was washed 5 times (5 minutes each). ECL reagent was prepared fresh and added 
to the blot to visualize the bands using the gel doc system.  
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II.2.7 Co-Immunoprecipitation 
Fresh lysates prepared from brain or CTLs were used for co-immunoprecipitation (Co-IP). 
Freshly washed (PBS, 0.1 % triton) Protein G Agarose beads were used to immunoprecipitate the 
protein of interest with its interacting partners. After determining the protein concentration, the 
required amount of protein lysate was taken for immunoprecipitation (IP). The lysates were 
incubated with 20 μl of Protein G Agarose beads on a shaker for 1 hr at 4 °C and then were 
centrifuged at 1000 *g for 2 minutes. The supernatant (containing the precleared lysates) was 
then split into two fractions, the first fraction was incubated with the primary antibody for the 
protein of interest, and the second fraction was incubated with an IgG control antibody. Samples 
were incubated for 2 hrs while kept on a shaker at 4 °C. At this step, the primary antibody should 
bind to its target bound to interacting proteins in the lysate solution. After 2 hrs, 30 μl prewashed 
Agarose beads were added to both sets and further incubated for 1 hr on a shaker at 4 °C. At this 
point, the antibody bound to protein complexes should bind to the Agarose beads. The samples 
were then centrifuged at 1000 *g for 2 minutes, then the supernatant was collected and the 
Agarose beads were washed with 1 ml washing buffer (PBS, 0.1 % triton) twice. The antibody-
protein complexes bound to the Agarose beads were eluted with 30 μl 1x LDS sample buffer 
with 10% βME. The total lysates (input), supernatant and the elution from the Agarose beads 
were then tested for the expression and/or enrichment of the corresponding protein by Western 
blot. 
II.2.7.1   IP using anti-Synaptobrevin2 antibody: 
WT CTLs were stimulated with anti-CD3/CD28 coated-beads for different time points to induce 
SNARE complex formation. After stimulation, cells were separated from the beads and lysed in 
lysis buffer (see solutions; section II.1.5.1). After measuring protein concentration, 150 μg of 
protein lysates (for each antibody) were used for Co-IP. Lysates were precleared as described 
above, then were incubated with 2 μl anti-Syb2 antibody (1mg/ml), or with 2 μl mouse IgG 
antibody (1mg/ml) for 2 hrs on a shaker at 4 °C. Pre-washed Agarose beads were then added, 
and incubated with the samples for one extra hour. The samples were then centrifuged. The 
supernatant was collected and the Agarose beads were washed twice with washing buffer and 
then eluted in 1x LDS sample buffer with 10% βME. 50 μg of total lysate, 50 μg of the 
supernatant and the whole elution from the beads were run on a polyacrylamide gel. The gel was 
transferred to a nitrocellulose membrane as described above. Then the membrane was probed 
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with different antibodies to check for proteins that co-immunoprecipitated with Syb2. Anti-
SNAP-23 antibody was used with 1:1000 dilution in 5% milk (dissolved in TBST), incubated for 
1 hr at RT, washed as described and then incubated with an anti-rabbit HRP conjugated 
secondary antibody (same for anti-CALM antibody). Anti-Stx11 antibody was also used to check 
whether Stx11 was co-immunoprecipitated with Syb2. It was used with a dilution of 1:500 in 5% 
BSA and incubated with the membrane overnight at 4 °C. After checking for the different 
antibodies, the membrane was stripped and reprobed with anti-Syb2 antibody at a 1:1000 
dilution in 5% milk, overnight at 4 °C. The membrane was then incubated with anti-mouse 
secondary-HRP antibody at a 1:1000 dilution for 1 hr at RT. 
II.2.8 Labeling of anti-RFP antibodies with fluorescent dyes  
In order to study the acidification of syb2-mRFP-containing (endo-Syb2) vesicles, a pH-sensitive 
dye, pHrodo green STP ester (increases in fluorescence with decreasing pH) (Miksa et al., 2009) 
and a pH-insensitive dye, Alexa405 were conjugated to anti-RFP antibody. The conjugation was 
performed using an antibody-labeling kit from Invitrogen according to the provider’s protocol. 
Briefly, 1 M solution of sodium bicarbonate was freshly prepared and 10 μl were added to a 
100 μl anti-RFP antibody (1mg/ml). The mixture was then added to the vial containing Alexa 
Fluor dye (Alexa405) and pHrodo green STP ester, mixed together and incubated for 1 hr at RT. 
During incubation, the purification column was prepared by adding 1.5 ml resin to the column 
and spinning it down at 1100 *g for 3 min. The reaction mixture was added to the column and 
centrifuged for 5 min at 1100 *g. The eluate contained the conjugated antibody is then ready to 
be used. 
For the anti-RFP antibody labeled with either of the Alexa Fluor dyes (Alexa-405/488/647) only, 
the procedure was similar except that only the Alexa Fluor dye was used for labeling the 
antibody. 
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Figure 9. Endocytosis of fluorescently-labeled antibody.  
A scheme showing endocytosis of a fluorescently-labeled antibody with a pH-dependent dye. The antibody binds its 
ligand and both are then endocytosed together. In the endocytosed vesicle the pH drops which induces the dye to 
fluoresce, thus the fate of the receptor and antibody can be followed. Source: promega.com (pH-Ab reactive dyes for 
screening antibody internalization).  
II.2.9 Electroporation of CTLs with different Rab protein constructs 
CD3/CD28 beads were removed from day 2 activated CTLs. CTLs were transfected overnight 
(12 hrs) with 6 μg of either of the following constructs, eGFP-Rab5, eGFP-Rab7 or eGFP-
Rab11. Electroporation was performed using Nucleofection kit (LONZA). Briefly, 2-3*106 cells 
were washed with PBS. Cells were then resuspended in 100 μl nucleofection solution with the 
corresponding plasmid DNA. Cells were kept in medium provided with the kit overnight at 
37 °C and with 5% CO2. 
II.2.10 Coating coverslips 
For all experiments, coverslips used were coated with 0.1 mg/ml polyornithine for 30 min at RT 
(glass coverslips were precleaned with 70% ethanol prior to coating). For studying acidification 
of endocytosed vesicles, anti-CD3-coated coverslips were used as a stimulation that mimics an 
antigen presenting cell or a target cell. For this experiment coverslips were first coated, as 
mentioned, with polyornithine, then with 30 μg/ml anti-CD3 antibody (diluted from 1 mg/ml 
stock) in a final volume of 30 μl for one coverslip (25 mm). The antibody was kept on the 
coverslips for 2 hrs at 37 °C, then the solution was aspirated and the coverslips were ready to be 
used. 
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II.2.11 Live imaging 
II.2.11.1 LSM microscope 
Live imaging experiments were performed using Zeiss laser scanning microscope 780 (LSM 
780).  LSM 780 is a confocal light microscope with the ability to acquire images either 
simultaneously or sequentially. It is equipped with a 32-channel GaAsP detector with active 
cooling and oversampling of photon counting to deliver highest sensitivity for better signal to 
noise ratio. This detector is also equipped with two side PMTs that expand the spectral working 
range and allow for imaging of samples with different signal intensities. The setup is equipped 
with an incubator chamber that can be kept at 37 °C with 5% CO2 as well, which can be used for 
live imaging experiments. A 63x oil immersion objective with a NA of 1.4 Plan-Apochromat 
was used for live imaging experiments. The ZEN software was used to acquire movies and 
images. Different wavelengths were used for exciting samples, 405 nm with a Diode 405 nm 
laser and 488, 561 and 633 nm with a multiple band beam splitter for 488/561/633 nm and a 
pinhole size of 1 airy unit (AU). To cover the range of the cell, confocal z-stacks were taken with 
a step size of 0.5 μm. 
II.2.11.2 Acidification of endocytosed Syb2-containing (endo-Syb2) vesicles 
In order to study acidification of endo-Syb2 vesicles an anti-RFP antibody that is coupled to 
Alexa405 and pHrodo green dyes (anti-RFP405/pHrodo) (1 mg/ml) was used. Alexa405 is a pH-
insensitive dye, so it will fluoresce immediately when the antibody is bound to Syb2-mRFP 
molecules at the plasma membrane, however pHrodo green is a pH-sensitive dye that is not 
fluorescent in neutral environment but it increases in fluorescence with increasing acidity (Miksa 
et al., 2009), i.e. even when the anti-RFP antibody is bound to the syb2-mRFP, no signal from 
pHrodo will be detected in neutral environment. Only upon endocytosis and acidification of 
these endocytosed vesicles will the signal from pHrodo be visible. 
II.2.11.2.1 Live imaging with anti-CD3-coated coverslips 
Sybki CTLs (CTLs isolated from Syb2-mRFP knock-in mice) were added to anti-CD3-coated 
coverslips at a concentration of 0.2*106 in 100 μl IMDM medium; CTLs were allowed to settle 
and imaged using LSM microscope, in the presence of anti-RFP405/pHrodo antibody (1 mg/ml). 
The signal from Alexa405 appeared an average of one minute earlier than that of pHrodo. 
MATERIALS AND METHODS 
 
53 
 
Acquisition frequency was 1 Hz. Movies were taken with a z-stack of 12 planes with a step size 
of 0.5 μm. The total number of cells analyzed was 34 cells from two different mice, with a total 
number of 48 endocytic events.  
II.2.11.2.2 Live imaging with P815 target cells 
Sybki CTLs were added to polyornithine-coated coverslips at a concentration of 0.2*106 in 90 μl 
IMDM medium, allowed to settle and imaged using LSM microscope. 10 μl of P815 target cells 
were then added to the coverslip at a final concentration of 0.1*106, along with anti-CD3 
antibody (1 mg/ml) and anti-RFP405/pHrodo (1 mg/ml). Acquisition frequency was 2 Hz. 
Movies were taken with a z-stack of 12 planes with a step size of 0.5 μm. The total number of 
cells analyzed was 9 cells from four different mice, with a total number of 15 endocytic events. 
II.2.12 Imaging using structured illumination microscope (SIM) 
II.2.12.1 SIM microscope 
In 1873 Ernst Abbe discovered that the resolution of microscopes is limited by the following 
formula: d= λ/2NA, where d, is the diffraction limit of light; λ, is the wavelength of light; and 
NA, is the numerical aperture of the objective (Abbe, 1873). Several microscopes were 
developed later that defy Abbe’s diffraction limit. The structured illumination microscope (SIM) 
is a super-resolution microscope that defies the diffraction limit of light. Illuminating the sample 
with a series of excitation light patterns generates a grid pattern similar to that generated by the 
moiré effect. The grid pattern is tilted in a certain angle to acquire successive images from the 
illuminated area (5 or 3 rotations). The produced series of images are then processed and 
reconstructed to generate a high-resolution image (Gustafsson, 2005). The axial resolution of the 
reconstructed images ranges between 150 and 300 nm.  
Images were acquired using ZEN software. An oil-immersion 63x objective with a NA of 1.4 
Plan-Apochromat was used to image different samples. Different wavelengths were used for 
exciting samples; the setup is equipped with several lasers, for example the lasers used included, 
an HR Diode 405, 488 and 642 nm lasers and an HR DPSS 561 nm laser. Thirty stacks were 
taken for each image with a step size of 0.2 μm to cover about 6 μm of the cell. 
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II.2.12.2 Fixation and labeling of cells 
CD8+ T lymphocytes isolated from sybki or WT mice were activated for 3 days with beads as 
described above. Cells were used for fixation either as resting cells, i.e. without P815 target cells 
or as conjugated cells, i.e. with P815 target cells. 
II.2.12.2.1  Resting cells 
Activated CTLs were removed from beads, washed with isolation buffer and then resuspended in 
IMDM medium at a concentration of 4*106 cell/ml. Then 50 μl CTLs were put on polyornithine-
coated glass coverslips (1mg/ml). Cells were allowed to adhere to the coverslip for 15 minutes at 
37 °C with 5% CO2. Then cells were washed once with PBS and then ice-cold 4% PFA was 
immediately added to the cells for 20 minutes. Fixed cells were washed twice with PBS and once 
with PBS containing 0.1 M glycine (quenching solution) for 3 minutes. The cells were again 
washed twice with PBS and kept at 4 °C. Cells were then ready for labeling. 
Fixed cells were permeabilized with PBS containing 0.1% triton for 20 minutes. Then cells were 
blocked with blocking solution (PBS with 0.1% triton, 2% BSA) for another 30 minutes. During 
this time the antibody dilutions were prepared in blocking buffer. After adding the primary 
antibody the coverslips were incubated for 1 hr at RT, and afterwards washed for 5 times (5 min 
each) with PBS (0.1% triton). Coverslips were then incubated with the corresponding secondary 
antibody, diluted in blocking buffer, for 1 hr at RT. The coverslips were washed for 5 times (5 
min each) and mounted on glass slides in 4 μl mounting medium (for 12 mm coverslips). 
Coverslips were allowed to dry for about 15 minutes and then kept at 4 °C, until imaged on the 
SIM microscope.   
II.2.12.2.2  Conjugated cells 
Sybki CTLs were removed from beads and washed with isolation buffer then resuspended in 
IMDM medium at a concentration of 8*106 cell/ml (transfected cells were treated the in same 
way, except that they were already removed from beads before transfection). P815 target cells 
were also washed with isolation buffer and then resuspended in IMDM medium at a 
concentration of 8*106 cells/ml, with anti-CD3 antibody at a concentration of 0.3 μg/μl. CTLs 
were then mixed with target cells just before adding them to the coverslips (1:1 ratio). Cells were 
incubated at 37 °C with 5% CO2 for different time points, and then fixed with ice-cold 4% PFA. 
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After fixation cells were treated as described above, if labeling with different antibodies was 
required, otherwise the coverslips were mounted directly after washing with PBS. 
II.2.13 Image analysis 
Images studied for colocalization of anti-RFP647 with the different Rab GTPases were analyzed 
using JACoP plugin in Fiji. Manders’ coefficient was calculated by JACoP. To analyze the 
experiments for granzyme B uptake into endocytosed-Syb2-containing (endo-Syb2) vesicles 
(carrying anti-RFP405 antibody), three-color colocalization analysis was performed. Fiji was 
used to obtain the number of colocalized Rab5/7 and endo-Syb2 pixels that also contained 
granzyme B. This was done by applying a threshold and converting all three channels 
individually to binary images such that all fluorescent pixels are in the foreground having a bit 
value of 255. First, the Rab5 and endo-Syb2 binary images were merged to obtain a resulting 
RGB image with the following parameters: background-Yellow (255,255,000); Rab5 green only 
(000,255,000); endo-Syb2 red only (255,000,000); colocalized pixels Black (000,000,000). 
Applying a color threshold based on hue saturation and brightness to this image results in an 
image (Rab plus endo-Syb2) in which the colocalized pixels are in the foreground. The number 
of colocalized pixels was calculated by dividing the raw integrated density by the mean intensity 
of the resulting image (Rab plus endo-Syb2). Next, Rab plus endo-Syb2 images were merged 
with the granzyme B binary image, and the resulting image was processed as described above to 
obtain the colocalized pixels between all three channels: Rab5/7, endo-Syb2, and granzyme B 
over time (Chang et al., 2016). 
II.2.14 Software 
A plasmid Editor (ApE), version 1.17, M. Wayne Davis. 
CorelDRAW, version 16.1.0.843, Corel Corporation. 
ImageJ, National Institutes of Health, Federal Government of USA. 
Office 2013, Microsoft. 
SigmaPlot Version 13, Systat Software, Inc. 
SnapGene Viewer 2.8, GSL Biotech LLC 
Zeiss Efficient Navigator (Zen) 2012, Carl Zeiss. 
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III. Results  
III.1  SNAP-23 is a t-SNARE required for cytotoxic granule (CG) fusion in 
mouse CTLs 
Our group have previously identified Syb2 as the v-SNARE and STX11 as a t-SNARE required 
for fusion in CTLs (Halimani et al., 2014; Matti et al., 2013). Studies on other types of immune 
cells like neutrophils (secretion of specific and tertiary granules) (Mollinedo et al., 2006), 
macrophages (TNFα secretion) (Pagan et al., 2003), mast cells (specialized secretory granules) 
(Guo et al., 1998; Paumet et al., 2000) and platelets (lysosome release) (Chen et al., 2000) have 
shown that SNAP-23 is a t-SNARE required for vesicle fusion in these cells. In order to define 
the identity of t-SNAREs in mouse CTLs, we performed immunoprecipitation using anti-Syb2 
antibody and checked for the co-immunoprecipitation of SNAP-23 and STX11 along with Syb2. 
Also, because recent experiments have shown that CALM is an adaptor protein required for 
Syb2 endocytosis from mouse CTLs (Chang et al., 2016), we examined whether CALM co-
immunoprecipitates with Syb2. To induce CG fusion and thus SNARE complex formation, CTLs 
from WT mice were activated with anti-CD3/CD28-coated beads for 0, 15, 30 or 60 minutes.  
After running the Western blot for the IP samples, the membrane was probed with anti-Syb2 
antibody. As shown in (Figure 10A) Syb2 was immunoprecipitated with anti-Syb2 antibody, at 
all time points of stimulation; no band was seen with IP using control IgG antibody. Syb2 was 
detected in the input samples (Figure 10A, right side), however it was barely visible in the IP-
supernatant, indicating that almost all Syb2 was immunoprecipitated from the input samples. 
Both blots were probed for other proteins that might be co-immunoprecipitated along with Syb2. 
Probing with anti-SNAP-23 antibody showed that SNAP-23 was co-immunoprecipitated with 
Syb2 only after 30 and 60 min of CTL stimulation (Figure 10A, left blot). SNAP-23 can also be 
detected in the input samples and also the IP-supernatant. Though STX11 could be detected in 
the lanes corresponding to the input and IP-supernatant, anti-STX11 antibody didn’t show any 
band of STX11 that co-immunoprecipitated with Syb2. GAPDH was used as a loading control 
for the input and IP-supernatant samples (Figure 10A, left blot). Figure 10B also shows a 
Western blot for IP using Syb2 antibody from unstimulated CTLs or CTLs stimulated for 30 
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min. Syb2 can be detected in the IP fraction and input but is not detected in the IP with control 
IgG antibody. The same membrane was probed with anti-CALM antibody to check whether 
CALM is co-immunoprecipitated with Syb2 under these conditions. A band corresponding to 
CALM is detected only in the input samples and the supernatant but not the IP samples. 
SNAP-23 is phosphorylated by a protein called SNARE kinase (SNAK) (Cabaniols et al., 1999) 
and is present in the cell in a phosphorylated and unphosphorylated forms. In order to detect both 
phosphorylated-SNAP-23 (p-SNAP-23) and un-phosphorylated-SNAP-23 (SNAP-23) we 
repeated the IP with anti-Syb2 antibody, but allowed the blot to run for longer time to better 
separate p-SNAP-23 and SNAP-23. In this experiment, WT CTLs were only stimulated for 15 
and 30 min with anti-CD3/CD28-coated beads. Again Syb2 could be detected in the IP with anti-
Syb2 antibody but not with the control IP (Figure 10B). Syb2 was also detected in the input 
samples but not in the IP-supernatant. When probing the blot with anti-SNAP-23 antibody, two 
bands corresponding to p-SNAP-23 and SNAP-23 could be detected in the input, but not in the 
IP with CTLs stimulated for 15 min. However after 30 min stimulation, a clear band of SNAP-23 
could be detected to be co-immunoprecipitated with Syb2, which corresponded to the un-
phosphorylated form of SNAP-23.  
Our data show that SNAP-23 is a t-SNARE involved in CG fusion in mouse CTLs, and only the 
un-phosphorylated form of SNAP-23 was incorporated into the SNARE complex. In spite of 
this, STX11 and CALM did not co-immunoprecipitate with Syb2, probably because the binding 
of Syb2 with these proteins is not favoured under the current experimental conditions. It could 
also be that the endogenous interaction between Syb2 and CALM for example is transient thus 
allowing only a small fraction of Syb2 to be bound to CALM at a time, rendering it undetectable 
in a Western blot. 
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Figure 10. Co-immunoprecipitation of Syb2 with SNAP-23, STX11 and CALM.  
Lysates from stimulated WT CTLs were used for immunoprecipitation with anti-Syb2 antibody, or with a control 
mouse IgG antibody. A,  A Western blot of the IP samples, the input from each time point and the supernatant after 
each IP probed with Syb2 antibody (upper blots), with SNAP-23 antibody (middle blots), or with STX11 antibody 
(lower blots). SNAP-23 was immunoprecipitated with Syb2 after 30 and 60 min of CTL stimulation, however, 
STX11 did not co-immunoprecipitate with Syb2. The membrane from input and supernatant samples was stripped 
and reprobed with GAPDH antibody as a loading control. B, Co-IP done using anti-Syb2 antibody with either 
unstimulated CTLs or stimulated for 30 min. Western blot for the IP samples did not detect CALM in the IP 
fraction, although it can be detected in the input samples and the supernatant. Syb2 is present in the IP samples and 
can be detected in the input but not in the IP with the control IgG. C, A similar experiment to that in (A) is shown, 
however here CTLs were stimulated for only 15 and 30 minutes. Blots were probed with anti-Syb2 (upper blots) and 
anti-SNAP-23 (lower blots) antibodies; notice that here SNAP-23 is present in two bands, in both the input and 
supernatant, which represent the phosphorylated and un-phosphorylated forms of SNAP-23. Only the lower band i.e. 
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the un-phosphorylated form of SNAP-23 is immunoprecipitated with Syb2. CALM: clathrin assembly lymphoid 
myeloid leukemia, IP: immunoprecipitation, SN: supernatant, SNAP-23: synaptosomal-associated protein 23, 
STX11: syntaxin-11, Syb2: synaptobrevin2. 
III.2  Proteins present on endocytosed Syb2-containing (endo-Syb2) vesicles 
After fusion of CGs, the vesicle components diffuse in the plasma membrane, where the SNARE 
proteins are in the cis-SNARE complex (all proteins are in the same membrane). The complex is 
dissociated by the ATPase NSF allowing individual SNARE proteins to be free at the plasma 
membrane where they are endocytosed and reused for further rounds of fusion. We have 
confirmed the results from Chang et al, which shows that endocytosis of Syb2 occurs in mouse 
CTLs (Chang et al., 2016) (see results below). To study endocytosis of Syb2, we used CTLs 
isolated from Syb2-mRFP knock-in (sybki) mice. Thus anti-RFP antibodies were used to track 
Syb2-mRFP. The anti-RFP antibodies were coupled to Alexa405, 488 or 647 dyes and either was 
then added to the extracellular medium containing CTLs. The epitope of the anti-RFP antibody is 
located in the vesicle lumen (i.e. the mRFP fused to Syb2 faces the vesicle lumen) and is thus 
exposed to the extracellular medium upon CG fusion. Endocytosis of Syb2-mRFP results in 
import of the bound antibody as well, marking the endocytosed Syb2-mRFP (endo-Syb2) with 
the fluorescent dye. Endo-Syb2 can then be tracked using the Alexa dye fluorescence. 
Endocytosis of Syb2 is important for the serial killing function of CTLs because it allows for the 
replenishment of CG v-SNAREs (Rothstein et al., 1978). In order to determine what other 
proteins may be endocytosed with Syb2, we used antibodies against these candidate proteins and 
looked at colocalization in endocytosed vesicles. 
III.2.1 SNAP-23 is endocytosed with endo-Syb2 in the same vesicle  
We have shown that SNAP-23 (synaptosomal-associated protein of 23 kDa) is a t-SNARE 
required for fusion in mouse CTLs. Therefore, we investigated whether SNAP-23 is endocytosed 
along with Syb2 in the same vesicle. For that purpose, sybki CTLs (magenta) were conjugated 
with target cells in the presence of anti-RFP488 (green) and fixed after 5, 10 and 15 min of target 
cell addition (Figure 11A). Afterwards, conjugated cells were washed, permeabilized and labeled 
with an anti-SNAP-23 antibody, followed by the corresponding secondary antibody coupled to 
Alexa647 (red, see Figure 11A). The third column shows a merged image of SNAP-23 and anti-
RFP488 (colocalization is detected in yellow). Quantification of colocalization between endo-
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Syb2 vesicles (containing anti-RFP647) and anti-SNAP-23 was performed using the JACoP (Just 
Another Colocalization Plugin) plugin from FIJI. The Manders’ coefficient obtained by JACoP 
is shown as a dot plot (Figure 11B) for the different time points. Manders’ coefficient was used 
instead of Pearson’s coefficient because the colocalization studied here is from one channel to 
the other and not between both channels (Bolte and Cordelieres, 2006), i.e. colocalization of anti-
RFP488 (endo-Syb2) with anti-SNAP23 and not the other way around. SNAP-23 showed a very 
good colocalization with anti-RFP488 based on Manders’ coefficient values at all time points 
tested here (Figure 11B). These results indicate that SNAP-23 is endocytosed with Syb2 in the 
same vesicle at least until they fuse with early endosomes (section III.3.1). 
 
Figure 11. SNAP-23 is present on the same vesicles like endo-Syb2.  
A, SIM images of sybki CTLs (magenta) conjugated with P815 target cells in the presence of anti-RFP488 (green) 
antibody and fixed after 5, 10 and 15 min. Fixed cells were labeled with SNAP-23 (red). The third column shows a 
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merged image of the anti-RFP488 channel with that of SNAP-23 (colocalization is seen in yellow). B, 
Quantification of colocalization between the endo-Syb2 vesicles and SNAP-23 using Manders’ coefficient is shown 
as dot plot for the different time points for CTL:target cell conjugation. Data are from three independent 
experiments. Scale bar: 5 μm. Sybki: Synaptobrevin2-mRFP knock-in, SNAP23: Synaptosomal-associated protein 
23 kDa 
 
III.2.2 ZAP70 is endocytosed with endo-Syb2 in the same vesicle  
Zeta-chain associated 70 kDa tyrosine phosphoprotein (ZAP70) is involved in initiating T cell 
receptor (TCR) responses in CTLs. It acts upstream in the signaling pathway leading to T cell 
activation, as it phosphorylates several proteins recruited to the forming IS to activate further 
downstream events (Wang et al., 2010). Due to its crucial function at the IS, we investigated 
ZAP70 endocytosis and whether it colocalizes with endo-Syb2. For this purpose, sybki CTLs 
(magenta) were conjugated with target cells in the presence of anti-RFP488 (green) and fixed 
after 5, 10 and 15 min (Figure 12A). Afterwards, conjugated cells were washed, permeabilized 
and labeled with an anti-ZAP70 primary antibody, followed by the corresponding secondary 
antibody coupled to Alexa647 (red, see Figure 12A). The third column shows a merge between 
the images from ZAP70 and anti-RFP488 (colocalization is detected in yellow). Quantification 
of colocalization between endo-Syb2 vesicles (containing anti-RFP488) and anti-ZAP70 was 
calculated using JACoP plugin from FIJI. The Manders’ coefficient obtained by JACoP is shown 
as a dot plot (Figure 12B) for the different time points. ZAP70 shows a very good colocalization 
with anti-RFP488 based on Manders’ coefficient values from all time points checked here 
(Figure 12B). As with SNAP-23, ZAP70 is endocytosed with Syb2 in the same vesicle at least 
until they fuse with early endosomes (section III.3.1). 
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Figure 12. ZAP70 is endocytosed in the same vesicle with endo-Syb2.  
A, SIM images of sybki CTLs (magenta) conjugated with P815 target cells in the presence of anti-RFP488 (green) 
antibody and fixed after 5, 10 and 15 min. Fixed cells were labeled with ZAP70 (red). The third column shows a 
merged image of the anti-RFP488 channel with that of ZAP70 (colocalization is seen in yellow). B, Quantification 
of colocalization between the endo-Syb2 vesicles and ZAP70 using Manders’ coefficient is shown as dot plot for the 
different time points for CTL:target cell conjugation. Data are from three independent experiments. Scale bar: 5 μm. 
Sybki: Synaptobrevin2-mRFP knock-in, ZAP70: zeta-associated protein of 70 kDa.  
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III.2.3 H+ V-ATPase is present on endo-Syb2 vesicles 
Since an acidic pH is a key feature of CGs, we investigated whether the H+ V-ATPase would be 
endocytosed directly with Syb2 in the same vesicle. Therefore, we investigated using high-
resolution microscopy whether the H+ V-ATPase is localized on nascent endo-Syb2 vesicles. 
Figure 13A shows SIM images of sybki CTLs (magenta) incubated with P815 target cells in the 
presence of anti-RFP488 antibody (green) and fixed after 5, 10 or 20 minutes of target cell 
addition, then stained with an antibody against a3 subunit of the H+ V-ATPase (red). The a3 
signal corresponding to the V-ATPase shows colocalization with endo-Syb2 vesicles even at the 
5 minute time-point of conjugation with target cells (Figure 13A, third column; colocalization 
can be detected in yellow). Colocalization of endo-Syb2 vesicles (containing anti-RFP488) with 
a3 subunit of the V-ATPase, quantified using Manders’ coefficient (Figure 13B), demonstrated a 
high degree of co-localization at all the given time points starting as early as 5 min of CTL:target 
cell incubation. This result indicates that the V-ATPase is already endocytosed along with Syb2, 
as the colocalization of fluorescent anti-RFP with the V-ATPase occurs at time points earlier 
than co-localization with early endosomes, which are the first organelles that nascent 
endocytosed vesicles fuse with (section III.3.1).  
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Figure 13. The a3 subunit of the V-ATPase colocalizes with endo-Syb2 vesicles.  
A, SIM images of sybki CTLs (magenta) conjugated with P815 target cells in the presence of anti-RFP antibody 
coupled to Alexa 488 (anti-RFP488, green). Cells were fixed at the indicated time points (5, 10 and 20 mins), 
permeabilized and labeled with an anti-a3 antibody, then with a secondary antibody coupled to Alexa 647 (red). 
Colocalization between a3 signal and anti-RFP488 is seen in yellow color in the merged image (third column), and 
colocalization between all three channels is seen in white color (the next to last column). B, Quantification of 
Manders’ coefficient of colocalization between the a3 subunit of the v-ATPase and anti-RFP488 of the endo-Syb2 
vesicles. Scale bar: 5 μm. Data are representative of two independent experiments. Error bars represent SEM. 
Numbers in the bar graphs represent the cell number per group. 
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III.2.4 H+ V-ATPase is colocalized with endo-Syb2 vesicles 1-2 min 
following exposure of Syb2-mRFP at the plasma membrane shown by 
live imaging 
We have shown that endo-Syb2 vesicles colocalized rapidly with H+ V-ATPase, prior to fusion 
with endosomal compartments (section III.3.1), using high resolution imaging of fixed cells. We 
wanted to investigate, using live imaging whether we would be able to detect the acidification of 
endo-Syb2 vesicles. The results from this experiment might indicate whether some of the CG 
membrane components are endocytosed together, which would be important for their maturation 
into CG. Since an acidic pH is a key feature of CGs, we investigated the time required for the 
acidification of endo-Syb2 vesicles. For this purpose, anti-RFP antibody, which detects fused 
Syb2-mRFP, was coupled to two different fluorophores, Alexa405 and pHrodo green which are 
pH-insensitive ( i.e. it is fluorescent in neutral and acidic environments) and pH-sensitive dye, 
respectively. PHrodo is not fluorescent in neutral environment, but it increases fluorescence with 
decreasing pH (Miksa et al., 2009). Figure 14A shows live cell imaging of a sybki CTL forming 
an immunological synapse (IS) with a P815 target cell in the presence of anti-RFP405/pHrodo. 
Upon CTL contact with the target cell, CGs (endogenously labeled with Syb2-mRFP) are 
polarized towards the IS (Figure 14A, third row). Immediately upon antibody binding, the 
Alexa405 signal is visible (Figure 14A, first row, yellow arrows), pHrodo is seen about two 
minutes later (Figure 14A, second row, yellow arrows). Detection of pHrodo signal indicates that 
Syb2-mRFP is already endocytosed in a compartment that has an acidic pH. The acidity of this 
endocytosed vesicle increases further, as seen by the constitutive increase in pHrodo signal 
(Figure 14A, second row). The merged image for all channels shows the colocalization of the 
fluorescent signals (Figure 14A, last row). Next, sybki CTLs were allowed to settle on an anti-
CD3-coated coverslips to induce IS formation. Fluorescently-labeled anti-RFP antibody was 
added to the medium, and upon CG fusion, signal from anti-RFP405 was visible first (Figure 
14B, first row, yellow arrows), and signal from anti-RFP-pHrodo, an average of one minute later 
(Figure 14B, second row, yellow arrows). Quantification of the time required for acidification of 
endo-Syb2 vesicles indicated that the average times for acidification were 125 ± 19.1 seconds for 
stimulation with target cells and 61 ± 6.2 seconds for stimulation with anti-CD3-coated 
coverslips. Data are representative of 9 cells from four independent experiments (Figure 14A) 
and 32 cells from two independent experiments (figure 14B). Variability in the time required for 
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acidification between the two methods used might be explained by the stimulus strength given to 
the CTL. Stimulation with anti-CD3-coated coverslips probably induces a stronger stimulation of 
the CTL than contact with the target cell, thus inducing faster exocytosis and endocytosis. 
 
Figure 14. Acidification of endo-Syb2 vesicles in CTLs.  
Confocal time lapse imaging of sybki CTLs (red) incubated with P815 target cells (A) or on an anti-CD3-coated 
coverslips (B) in the presence of anti-RFP antibody coupled to Alexa405 (blue) and pHrodo green (green). Initially 
only Alexa405 signal is seen upon antibody binding to exposed mRFP (A and B, first row). Only upon acidification 
of endo-Syb2 vesicles, pHrodo signal appears (A and B, second row). The bright field images show the CTL with 
the target cell (A) or only CTL (B). The merged images show the colocalization of the anti-RFP405 and pHrodo 
together and with sybki (A and B, last row). Numbers at the top indicate time scale. Scale bar, 3 μm. 
III.3  Trafficking of endo-Syb2 vesicles through the endosomal pathway 
We have shown that Syb2 is endocytosed in mouse CTLs along with other proteins in the same 
vesicle (SNAP-23 and ZAP70), including other CG membrane components (H+ V-ATPase). In 
the next step, we were interested in elucidating the pathway of maturation of endo-Syb2 vesicles 
to CG. To define the main endosomal hubs, different markers labelling each of these were 
utilized. We used eGFP-Rab5 to label early endosomes, eGFP-Rab7 to label late endosomes 
(Rink et al., 2005) and eGFP-Rab11 to label recycling endosomes. 
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III.3.1 Endo-Syb2 vesicles reach early endosomes within 15 min of target 
cells’ addition  
The first intracellular organelles that nascent endocytosed vesicles fuse with are early 
endosomes. Therefore we investigated the colocalization of endo-Syb2 with early endosomes 
using Rab5 as the organelle marker (Chavrier et al., 1990). Sybki CTLs were transfected with a 
construct encoding eGFP-Rab5 by electroporation. Transfected cells were conjugated with P815 
target cells for 5, 15, 30 and 60 minutes in the presence of anti-RFP647 antibody. Figure 15A 
shows SIM images of the conjugated cells, with eGFP-Rab5 shown in green, Syb2-mRFP in red 
and anti-RFP647 antibody corresponding to endo-Syb2 in magenta. The colocalization between 
all three channels is seen in white color in the merged images (Figure 15A). Quantification of 
colocalization between endo-Syb2 vesicles (containing anti-RFP647) and the eGFP-Rab5 was 
calculated using the JACoP plugin form FIJI. The Manders’ coefficient obtained by JACoP is 
plotted and shown as a dot plot (Figure 15B) for the different time points. We were interested to 
check the fraction of endo-Syb2 that colocalizes with early endosomes, thus we used Manders’ 
coefficient for quantification of this colocalization (Bolte and Cordelieres, 2006). Colocalization 
started low (0.31 ± 0.02) at 5 minutes of CTL:target cell conjugation but increased to a 
maximum (0.51 ± 0.02) after 15 min, to decrease again after 30 min (0.37 ± 0.02) and then reach 
a minimum (0.29 ± 0.02) after 60 min of conjugation (Figure 15B). Statistical analysis shows a 
significant difference between the Manders’ coefficient at 15 min with that at 5 min (P<0.001) 
and between the values at 15 min and at 30 min (P<0.001). Mander’s coefficient value of 0.2 for 
example, indicates that 20% of the signal from one channel colocalizes with the signal from the 
other channel (Bolte and Cordelieres, 2006). Therefore, these data show that at least 50% of 
endo-Syb2 colocalizes with early endosomes after 15 min of CTL:target cell conjugation. 
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Figure 15. Endo-Syb2 colocalizes with early endosomes 15 min after endocytosis.  
A, SIM images of sybki CTLs (red) transfected with eGFP-Rab5 (green) conjugated with P815 target cells in the 
presence of anti-RFP647 antibody (magenta) and fixed at the indicated time points. The next to last column shows 
the merged images from all three channels, with white color indicating colocalization between these channels. Scale 
bar: 5 μm. B, the graph represents quantification of the Manders’ coefficient for colocalization between eGFP-Rab5 
and endocytosed vesicles containing anti-RF647 antibody (endo-Syb2), at the different time points of CTL:target 
cell conjugation. Data are from three independent experiments. Red circles represent mean ± SEM for each time 
point. Asterisks indicate significance in one-tailed Student's t-test; *P<0.05, ***P<0.001. Sybki: Synaptobrevin2-
mRFP knock-in.  
III.3.2 Endo-Syb2 vesicles show no colocalization with recycling 
endosomes   
Endocytosed proteins that reach the early endosomes are either recycled back to the plasma 
membrane via recycling endosomes (Sonnichsen et al., 2000), or they further traffic to late 
endosomes (Schmid et al., 1988). Sybki CTLs were transfected with a construct encoding eGFP-
Rab11, which labels recycling endosomes, to test whether endo-Syb2 vesicles fused with the 
recycling endosomes. After incubation with P815 target cells in the presence of anti-RFP647, 
CTLs were fixed at 5, 15, 30 and 60 min. Figure 16A shows SIM images of the conjugated cells 
with eGFP-Rab11 shown in green, Syb2-mRFP in red and endo-Syb2 vesicles (containing anti-
RFP647) in magenta. The colocalization between all three channels is seen in white color in the 
merged image column (Figure 16A). Quantification of colocalization between endo-Syb2 
vesicles and the eGFP-Rab11 was calculated using JACoP plugin from FIJI. The Manders’ 
coefficient obtained by JACoP is plotted and shown as a dot plot (Figure 16B) for the different 
time points. In contrast to the results obtained with eGFP-Rab5, colocalization of endo-Syb2 was 
minimal with eGFP-Rab11 (0.27 ± 0.02 at 5 min to 0.24 ± 0.03 at 60 min). Statistical analysis 
showed no significant difference between the Manders’ coefficient for any of the time points 
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shown in the figure. Therefore these data show that the main pathway followed by endo-Syb2 
might not include recycling through recycling endosomes. 
 
Figure 16. Endo-Syb2 does not traffic through recycling endosomes.  
A, SIM images of sybki CTLs (red) transfected with eGFP-Rab11 (green) conjugated with P815 target cells in the 
presence of anti-RFP647 antibody (magenta) and fixed at the indicated time points. The next to last column shows 
the merged images from all three channels, with white color indicating colocalization between these channels. Scale 
bar: 5 μm. B, the graph represents quantification of the Manders’ coefficient for colocalization between eGFP-
Rab11 and endocytosed vesicles containing anti-RF647 antibody (endo-Syb2), at the different time points of 
CTL:target cell conjugation. Data are from two independent experiments. Red circles represent mean ± SEM for 
each time point. Sybki: Synaptobrevin2-mRFP knock-in. 
III.3.3 Endo-Syb2 vesicles reach late endosomes 30-60 min after 
CTL:target cell conjugation 
Endo-Syb2 vesicles showed minimal colocalization with eGFP-Rab11 indicating that these 
vesicles do not traffic through the recycling endosomes. To test whether these vesicles traffic 
through the late endosomes, we transfected sybki CTLs with a construct encoding eGFP-Rab7, 
as a marker for late endosomes and examined the localization of endo-Syb2 in relation to that of 
late endosomes. Transfected cells were incubated with P815 target cells in the presence of anti-
RFP647 and fixed at 5, 15, 30 and 60 min. Figure 17A shows SIM images of the conjugated cells 
with eGFP-Rab7 shown in green color, Syb2-mRFP in red color and endo-Syb2 (containing anti-
RFP647) in magenta color. The colocalization between all three channels is seen in white color 
in the merged image column (Figure 17A). Quantification of colocalization between endo-Syb2 
and the eGFP-Rab7 was calculated using JACoP plugin form FIJI. The Manders’ coefficient 
obtained by JACoP is shown as a dot plot (Figure 17B) for the different time points. The 
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colocalization between eGFP-Rab7 and endo-Syb2 started low (0.17 ± 0.02) after 5 min of 
CTL:target cell conjugation and started to increase progressively after 15 min (0.33 ± 0.02) and 
30 min (0.4 ± 0.02) to reach a maximum after 60 min (0.45 ± 0.02) of CTL:target conjugation. 
Statistical analysis shows significant difference in the Manders’ coefficient at 5 min to that at the 
other time points studied (P<0.001), and between 15 min and 60 min (P<0.012). These results 
implicate that endo-Syb2 is probably trafficked mainly from the early endosomes to late 
endosomes and not through recycling endosomes. 
 
Figure 17. Endo-Syb2 colocalizes with late endosomes 30-60 min after endocytosis.  
A, SIM images of sybki CTLs (red) transfected with eGFP-Rab7 (green) conjugated with P815 target cells in the 
presence of anti-RFP647 antibody (magenta) and fixed at the indicated time points. The next to last column shows 
the merged images from all three channels, with white color indicating colocalization between these channels. Scale 
bar: 5 μm. B, the graph represents quantification of the Manders’ coefficient for colocalization between eGFP-Rab7 
and endo-Syb2 vesicles containing anti-RF647 antibody (endo-Syb2), at the different time points of CTL:target cell 
conjugation. Data are from two independent experiments. Red circles represent mean ± SEM for each time point. 
Asterisks indicate significance in one-tailed Student's t-test; *P<0.05, ***P<0.001. Sybki: Synaptobrevin2-mRFP 
knock-in.  
III.4  Acquisition of granzyme B by endo-Syb2 vesicles 
The main pathway followed by endo-Syb2 is from early endosomes to late endosomes. However, 
since cytotoxic proteins such as granzyme B constitute a hallmark of a mature cytotoxic granule, 
we next investigated the time point at which granzyme B is incorporated into endo-Syb2 vesicles 
to determine whether this occurs in early or late endosomes. For that purpose, we transfected 
sybki CTLs with either eGFP-Rab5 or eGFP-Rab7 and then conjugated these cells with P815 
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target cells in medium containing anti-RFP405 to label endo-Syb2. Cells were fixed at various 
time points after target cell addition and then washed, permeabilized and stained with an anti-
granzyme B antibody coupled to Alexa647. 
III.4.1 Endo-Syb2 vesicles do not acquire granzyme B at Rab5-
containing early endosomes 
In order to address whether endo-Syb2 vesicles regain granzyme B from early endosomes, sybki 
CTLs were transfected with a construct encoding eGFP-Rab5 (green) to label early endosomes 
and conjugated with P815 target cells in the presence of anti-RFP antibody coupled to Alexa405 
(anti-RFP405, blue) to label endo-Syb2 vesicles (Figure 18A). The figure shows SIM images of 
CTL:target cell conjugates at the different time points of conjugation labeled with an anti-
granzyme B antibody coupled to Alexa647 (red). The images from the anti-RFP405 channel and 
that of eGFP-Rab5 are shown as a merged image for each time point in the third column 
(colocalization is shown as cyan) (Figure 18A). This merged image at each time point is again 
merged with the corresponding granzyme B image to produce the merged image of all three 
channels shown one before the last column (colocalization is seen in white) (Figure 18A). To 
find out at which time point is granzyme B reincorporated into the endo-Syb2 vesicles, we did a 
three-channel colocalization. First, we calculated the number of colocalized pixels between the 
anti-RFP405 (endo-Syb2) and eGFP-Rab5 by obtaining a corresponding image showing only the 
colocalized pixels in the foreground (anti-RFP405+eGFP-Rab5) (Figure 18B) (see Materials and 
Methods). The resulting image was then merged with the corresponding image containing only 
granzyme B fluorescent pixels in the foreground (Figure 18C) in order to finally obtain an image 
that contained the colocalized anti-RFP405+eGFP-Rab5 pixels having also granzyme B (anti-
RFP405+eGFP-Rab5+granzyme B) (Figure 18C). The graphs (Figure 18B-D) show the 
quantification of the corresponding pixel number at each of the aforementioned steps at the 
different time points of CTL:target cell conjugation. Colocalization between eGFP-Rab5 and 
anti-RFP405 using the above described common pixel analysis method (Figure 18B), showed 
maximum colocalization after 15 min of CTL:target cell conjugation that decreased again at 30 
to 60 min after conjugation. These results further confirm the results obtained by analysis using 
Manders’ coefficient for colocalization (Section III.3.1; Figure 15B). Figure 18C shows the 
number of colocalized anti-RFP405, eGFP-Rab5 and granzyme B fluorescent pixels from all 
three channels at the indicated time points of CTL:target cell conjugation. The pixel ratio (pixel 
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values from figure 18B/pixel values from figure 18C) is shown as a percentage in figure 18D for 
each time point of conjugation; it indicates the increase of granzyme B accumulation with endo-
Syb2 in the early endosomes. Initially the percentage of pixel colocalization is 5% at 5 min and 
only increases maximally to 10% after 30 min of conjugation. These results imply that endo-
Syb2 vesicles do not acquire granzyme B at the early endosomal stage. 
 
Figure 18. Granzyme B is not acquired by endo-Syb2 vesicles from the Rab5-containing early endosomes. 
Sybki CTLs were transfected with eGFP-Rab5 for 12 hrs and then incubated with P815 target cells in the presence 
of an anti-RFP antibody coupled to Alexa405 (anti-RFP405). Cells were then fixed after the indicated time points. 
A, SIM images of representative cells for each time point. RFP-405 (blue, 1st column), eGFP-Rab5 (green, 2nd 
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column), merge of these two channels (cyan, 3rd column), Granzyme B (red, 4th column), merge of all channels (the 
next to the last column) and the last column with bright field showing CTLs and target cells. B, Shows the 
quantification of colocalized pixels between eGFP-Rab5 and endo-Syb2 vesicles (anti-RFP405) at the different time 
points indicated, with maximum colocalization after 15 minutes of CTL: target cell conjugation. C, Quantification of 
the colocalized pixels between colocalized pixels from (B) and granzyme B. D, Percentage of the ratio of 
colocalized pixels between all three channels to that of the ones from eGFP-Rab5 and anti-RFP405. Scale bar: 5 μm. 
Data are from four independent experiments. Asterisks indicate significance in one-tailed Student's t-test; *P<0.05, 
**P<0.01, ***P<0.001. Sybki: Synaptobrevin2-mRFP knock-in, gzm B: granzyme B. 
III.4.2  Endo-Syb2 vesicles colocalize with granzyme B at the late 
endosomes 60 min after CTL:target cell conjugation  
Because we didn’t find much colocalization of (endo-Syb2+eGFP-Rab5) with granzyme B, we 
thought that the early endosomes are not the site where granzyme B is acquired by endo-Syb2 
vesicles. To further address other potential sites at which granzyme B could be acquired, we 
transfected sybki CTLs with a construct encoding eGFP-Rab7 to label late endosomes. Endo-
Syb2 vesicles show maximum colocalization with late endosomes at 60 min after CTL:target cell 
conjugation (Section III.3.3; Figure 17B).  
Figure 19A shows SIM images of sybki CTLs transfected with eGFP-Rab7 (green) and 
conjugated with P815 target cells in the presence of anti-RFP405 (blue) and fixed after different 
time points (5, 15, 30 and 60 min). Fixed cells were then stained with anti-granzyme B antibody 
coupled to Alexa647 (red). The images from the anti-RFP405 channel and that of eGFP-Rab7 
are shown as a merged image for each time point in the third column (colocalization is shown as 
cyan). This merged image at each time point is again merged with the corresponding granzyme B 
image to produce the merged image of all three channels and is shown in the next to last column 
(colocalization is seen in white) (Figure 19A). We performed a three-channel colocalization to 
analyze this set of data as well, to determine whether granzyme B is incorporated into the endo-
Syb2 vesicles at the late endosomes and at which time point. First, we calculated the number of 
colocalized pixels between the anti-RFP405 (endo-Syb2) and eGFP-Rab7 by obtaining a 
corresponding image showing only the colocalized pixels in the foreground (anti-
RFP405+eGFP-Rab7) (Figure 19B) (see Materials and Methods). The resulting image was then 
merged with the corresponding image containing only granzyme B fluorescent pixels in the 
foreground in order to finally obtain an image that contained the colocalized anti-
RFP405+eGFP-Rab7 pixels having also granzyme B (anti-RFP405+eGFP-Rab7+granzyme B) 
(Figure 19C). The graphs (Figure 19B-D) show the quantification of the corresponding pixel 
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number at each of the aforementioned steps at the different time points of CTL:target cell 
conjugation. Colocalization between eGFP-Rab7 and anti-RFP405 using the above described 
common pixel analysis method (Figure 19B), showed an increase in colocalization after 30 min 
of CTL:target cell conjugation to reach a maximum after 60 min conjugation. These results 
further confirm the results obtained by analysis using Manders’ coefficient for colocalization 
(Section III.3.3; Figure 17B). Figure 19C shows the number of colocalized anti-RFP405+eGFP-
Rab7+granzyme B pixels at the indicated time points of CTL:target cell conjugation. The 
number of colocalizing pixels starts to increase after 30 min of endocytosis to reach a maximum 
after 60 min, which can be related to the time points where the highest colocalization was seen 
between anti-RFP405 and eGFP-Rab7. This correlation indicates that granzyme B is 
incorporated into the endo-Syb2 vesicles at the late endosomes. The pixel ratio (pixel values 
from figure 19B/ pixel values from figure 19C) is shown as a percentage in figure 19D for each 
time point of conjugation; it indicates the increase of granzyme B accumulation with endo-Syb2 
colocalized with late endosomes. This graph shows that about 30% of granzyme B pixels 
colocalize with endo-Syb2 in the late endosomes. These results imply that endo-Syb2 vesicles 
would acquire granzyme B at the late endosomal stage. 
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Figure 19. Granzyme B is acquired by endo-Syb2 vesicles from the Rab7-containing late endosomes.  
Sybki CTLs were transfected with eGFP-Rab7 for 12 hrs and then incubated with P815 target cells in the presence 
of anti-RFP antibody coupled to Alexa405 (anti-RFP405). Cells were then fixed after the indicated time points. A, 
SIM images of representative cells for each time point. Anti-RFP405 (blue, 1st column), eGFP-Rab7 (green, 2nd 
column), merge of these two channels (cyan, 3rd column), Granzyme B (red, 4th column), merge of all channels (the 
next to the last column) and the last column with bright field showing CTLs and target cells. B, Shows the 
quantification of colocalized pixels between eGFP-Rab7 and endo-Syb2 vesicles (anti-RFP405) at the different time 
points indicated, with maximum colocalization after 60 minutes of CTL: target cell conjugation. C, Quantification of 
the colocalized pixels between colocalized pixels from (B) and granzyme B. D, Percentage of the ratio of 
colocalized pixels between all three channels to that of the ones from eGFP-Rab7 and anti-RFP405. Data are from 
four independent experiments. Scale bar: 5 μm. Asterisks indicate significance in one-tailed Student's t-test; 
*P<0.05, **P<0.01, ***P<0.001. Sybki: Synaptobrevin2-mRFP knock-in, gzm B: granzyme B. 
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IV. Discussion 
The data presented here show that synaptobrevin2 (Syb2), the v-SNARE of cytotoxic granules 
(CGs) of mouse Cytotoxic T lymphocytes (CTLs), interacts with SNAP-23 to drive exocytosis of 
the CTL’s CGs, thus identifying SNAP-23 as a t-SNARE required for CG fusion in these cells. 
After fusing with the plasma membrane, CG membrane protein Syb2 is endocytosed in a vesicle 
that is acidified in one to two minutes as shown by live imaging. These endocytosed vesicles 
colocalize with the a3 subunit of the V-ATPase’s V0 domain as early as 5 minutes after 
CTL:target cell conjugation. Syb2 is endocytosed along with ZAP70 and SNAP-23 into a vesicle 
which reaches the early endosomes within 15 min of CTL:target cell conjugation. From the early 
endosomes, Syb2, moves to the late endosomes without entering the recycling endosomes. Syb2 
exhibits maximum colocalization with the late endosomes within 60 min of target cell addition. 
Endo-Syb2 vesicles acquire granzyme B from late endosomes, marking the emergence of fully 
mature CGs that are ready to undergo a second round of fusion to kill target cells. 
IV.1  SNAP-23 is a t-SNARE required for CG fusion in mouse CTLs 
Our group has previously shown that Syb2 is the v-SNARE (Matti et al., 2013) and that STX11 
is one of the t-SNAREs (Halimani et al., 2014) required for fusion of CGs in mouse and human 
CTLs, respectively. Fusion of the CGs with the plasma membrane requires a v-SNARE at the 
CG membrane and two or three t-SNAREs at the plasma membrane (depending on the number 
of α-helices they contribute to the forming SNARE complex). We then determined what is/are 
the other t-SNARE/s involved in CG fusion in mouse CTLs. A likely candidate t-SNARE for 
secretion of CGs in CTLs was SNAP-23, since it widely expressed at the plasma membrane of 
various types of immune cells and responsible for the secretion of different types of vesicles 
from mast cells (Paumet et al., 2000), eosinophils ((Logan et al., 2002), and platelets (Chen et al., 
2000; Feng et al., 2002). SNAP-23 and syntaxin-4 both t-SNAREs expressed in CTLs are found 
to polarize to the IS upon conjugation of the CTL with an antigen presenting cell (APC) (Das et 
al., 2004).  
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WT CTLs were stimulated with anti-CD3/CD28-coated beads to induce exocytosis. In order to 
identify whether SNAP-23 is a t-SNARE required for CG fusion in mouse CTLs, an 
immunoprecipitation (IP) using anti-Syb2 antibody was performed from WT CTL lysates 
harvested at different time points after stimulation. A band corresponding to SNAP-23 
immunoprecipitated with Syb2 after 30 and 60 min of CTL stimulation (Figure 10A).  
The discrepancy in the time required for detecting co-immunoprecipitated SNAP-23 with Syb2 
(detected after 30 min of bead stimulation) and that of Syb2 endocytosis into the different 
endocytic compartment (Syb2 already fuses with early endosomes after 15 min of CTL:target 
cell conjugation) is probably due the stimulation of CTLs in the different experiments. For the IP 
experiment, CTLs were stimulated with anti-CD3/CD28-coated beads to induce a high number 
of CTLs in order to produce enough protein to be used simultaneously for the different IP 
conditions. Target cells (the stimulus used for other experiments) could not be used to stimulate 
CTLs in this experiment because their presence would have contaminated the lysate used for the 
IPs. Furthermore, we used sybki CTLs stimulated with anti-CD3/CD28-coated beads, similarly 
to WT CTLs for the IP experiment, in the presence of anti-RFP647 to detect the amount of fused 
and endo-Syb2 with such a stimulation. The results of this experiment showed that anti-RFP647 
detected fused Syb2 at the plasma membrane mostly after 30 min of bead-stimulation, consistent 
with the time window shown with the IP experiment for the formation of the SNARE complex 
(data not shown). 
In another independent immunoprecipitation experiment using anti-Syb2 antibody, in which the 
gel was allowed to run for a longer time to allow for a better separation of the bands (Figure 
10B), we detected two bands of SNAP-23 in the input and supernatant lanes corresponding to the 
phosphorylated and un-phosphorylated forms of SNAP-23. Interestingly, only the un-
phosphorylated form of SNAP-23 was co-immunoprecipitated with Syb2 after 30 min of CTL 
stimulation (Figure 10C). In B cells, SNAP-23 phosphorylation by the specific SNAK kinase, 
enhances the assembly of SNAP-23 into t-SNARE complexes. Surprisingly, the phosphorylated 
SNAP-23 resided exclusively in the cytosol and only the un-phosphorylated form of SNAP-23 
was incorporated into the t-SNARE complexes. The authors concluded that the increase of 
SNARE complex assembly upon overexpression of SNAK in Hela cells was due to an increase 
of the overall expression and stability of de novo synthesized SNAP-23, which alters the kinetics 
of SNAP-23 binding to the complex (Cabaniols et al., 1999). Thus the results from B cells are 
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consistent with our conclusion that un-phosphorylated SNAP-23 engages in the SNARE 
complex. 
Finally, we tested whether STX11 co-immunoprecipitated with Syb2 as it is has been shown to 
be the t-SNARE required for CG fusion in human CTLs. However, no band corresponding to 
STX11 could be detected in the IP fraction with Syb2 (Figure 10A). It may be that our 
experimental conditions hinder Syb2-STX11 interaction or that there is a different combination 
of t-SNAREs in mouse CTLs. 
IV.2  H+ V-ATPase is endocytosed along with Syb2, the v-SNARE of CGs, into 
early endosomes 
CGs are acidic with a pH value near 5.5 (Burkhardt et al., 1990) where the acidic pH is 
maintained by the action of the vesicular H+-adenosine triphosphatase (H+ V-ATPase). The V-
ATPase is a complex protein composed of two mutli-subunit domains V0 and V1. V0 is the 
transmembrane domain responsible for translocation of protons from the cytosol to the vesicle 
lumen and V1 is the cytosolic domain with the ATPase activity (Forgac, 2007).  
In an attempt to study the V-ATPase function and its role in synaptic vesicle exocytosis, Poëa-
Guyon et al. abolished the compartmental proton gradient by using inhibitors or acute photo-
inactivation of V0 or V1 domains’ subunits (Poea-Guyon et al., 2013). Inhibitors used included 
bafilomycin, a known pharmacological specific inhibitor of the V-ATPase, and an alkalizing 
agent, ammonium chloride, which reduces the acidity of different vesicular compartments (Wang 
and Hiesinger, 2013). The authors found that ammonium chloride but not bafilomycin blocked 
exocytosis of synaptic vesicles. Treatment with bafilomycin was able to override the inhibitory 
effect of ammonium chloride on exocytosis. The increased association of the V0-V1 domains 
upon ammonium chloride treatment and increased free V0 domain with bafilomycin treatment 
led the authors to conclude that the free V0 domain is required for the vesicles to be exocytosed. 
In another study, neutrophils pretreated with bafilomycin also showed an increase in surface 
expression of a2 subunit of the V0 domain that is mainly localized to the primary granules 
(Gilman-Sachs et al., 2015). The ‘a’ subunit of V0 domain has four isoforms: a1, a2, a3, and a4 
that are expressed differentially in different tissues and on different vesicles at the cellular level. 
The a3 isoform is expressed in several tissues such as liver, heart, kidney, brain, and spleen and 
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in osteoclasts where mutations in the gene expressing this isoform lead to osteopetrosis 
(Matsumoto et al., 2014). Acute photo-inactivation of a1 subunit of the V0 domain decreased 
secretion from neuronal and chromaffin cells but not when the A1 subunit of the V1 domain was 
inactivated (Poea-Guyon et al., 2013). The experiments above show that vesicle fusion with the 
plasma membrane requires the dissociation of the V0-V1 domain of the V-ATPase. The V0 
domain of the V-ATPase also plays a role in vacuolar fusion in yeast, as mutations in V0 showed 
more dramatic effects than those of V1 on vacuolar fusion, which indicates that V0 has roles 
other than vacuolar acidification (Bayer et al., 2003). Taken together these data show that V0-V1 
dissociation is required for vesicle fusion, and that V0 might be involved in vesicle fusion. 
The V0 domain of the V-ATPase has been shown to interact with Syb2 on synaptic vesicles even 
when incorporated into the SNARE complex (Morel et al., 2003). Using an antibody against the 
a3 subunit of the V0 domain, we saw colocalization between endo-Syb2 vesicles and the a3 
subunit (Figure 13A) quantified by the Manders’ coefficient for colocalization. Values for 
Manders’ coefficient were 0.65 ± 0.07 after only 5 min and stayed high even after 15 min of 
CTL:target conjugation (0.73 ±0.06 after 10 min and 0.78 ± 0.07 after 15 min) (Figure 13B). 
This data shows that a3 colocalized with endo-Syb2 at 5 and 10 min time points, i.e. before 
endo-Syb2 fuses with early endosomes (see below, section IV.3). In a following experiment, we 
showed that endo-Syb2 vesicles are acidified within one to two min of Syb2-mRFP exposure at 
the plasma membrane, using live imaging with anti-RFP antibodies coupled to Alexa405 and to 
pH-sensitive pHrodo green dyes. This delay may correspond to the time required for Syb2 to be 
incorporated into a vesicle along with the V0 subunit, where the V1 would then associate with 
the membrane-bound V0 domain to establish once again a functional proton pump. In live 
imaging we observed a gradual increase in the intensity of pHrodo-green signal, indicating a 
continuous increase of acidity of the endocytosed vesicle (Figure 14). Thus we speculate that the 
nascent endo-Syb2 vesicles are acidified immediately by the V-ATPase, even before fusion with 
early endosomes.  
IV.2.1 SNAP-23 and ZAP70 are endocytosed along with endo-Syb2 into 
early endosomes 
It has been shown using immunostaining that Syb2 endocytosis is clathrin-mediated and that 
CALM is a specific adaptor protein for Syb2 endocytosis (Chang et al., 2016). We did an 
DISCUSSION 
 
80 
 
immunoprecipitation experiment with stimulated CTL lysates using anti-Syb2 antibody to 
determine whether CALM co-immunoprecipitates with Syb2 (Figure 10B). Although Syb2 can 
be immunoprecipitated, no band corresponding to CALM could be detected to be co-
immunoprecipitated along with Syb2. This might indicate that the interaction between CALM 
and Syb2 is probably transient or that the conditions tested here for IP are not optimal to favor an 
interaction between Syb2 and CALM. Using GST fusion of the CALM-ANTH domain and His6-
Syb2 (N-terminus), Koo et al could show that CALM is an adaptor protein for Syb2 (Koo et al., 
2011a). Further optimization of our conditions might favor Syb2-CALM interaction and thus 
allow for co-immunoprecipitation of CALM along with Syb2.   
We have shown above that Syb2 is endocytosed in a vesicle that contains at least the V0 domain 
of the H+ V-ATPase within one to two minutes of Syb2 exposure at the plasma membrane, i.e. 
CG fusion. We wanted to test for other proteins that are endocytosed in the same vesicle as Syb2. 
For this reason, we used antibodies against SNAP-23 (Figure 11), which we have shown above is 
a t-SNARE required for CG fusion, and ZAP70 (Figure 12), a signaling protein that acts 
upstream in the signaling pathway after CTL contact with a target cell, to test whether these 
proteins were endocytosed with Syb2. 
It has been shown that both v- and t-SNAREs can reside on the same vesicle and they can 
interact with each other on the same membrane. STX11 and SNAP-23 were found to colocalize 
at the late endosomes and TGN where they probably form a complex at a steady state, although 
SNAP-23 was mainly localized to the plasma membrane (Valdez et al., 1999). Syntaxin 1 and 
SNAP-25, the t-SNAREs required for synaptic vesicle (SV) fusion, were found on recycling SVs 
and account for about 6% of the protein content of purified SVs in comparison to 8.7% for Syb2 
(Walch-Solimena et al., 1995). These results are in contradiction with other data indicating that 
synaptic vesicles maintain their composition during successive rounds of exo- and endocytosis 
(Valtorta et al., 1988). Our immunostaining data show that SNAP-23 colocalized with vesicles 
containing Syb2 as early as 5 min and till at least 15 min (probably in early endosomes) of 
CTL:target cell conjugation, with a Manders’ coefficient staying above 0.7 (Figure 11). These 
data indicate that t-SNAREs of CTLs can be recycled with CG components, including the v-
SNARE Syb2. Following CG fusion, t- and v-SNAREs on the plasma membrane might be 
endocytosed into the same vesicle until they fuse with early/sorting endosomes. Since we show 
that Syb2 traffics from early to late endosomes, it might be that at later time points (30 or 60 
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min) Syb2 does not colocalize with SNAP-23. This is expected since the t-SNAREs are likely 
sorted via recycling endosomes and then delivered to the plasma membrane for subsequent 
rounds of fusion. Endocytosis of t-SNAREs along with CG components in the same vesicle 
might also aid in the fusion of the nascent endocytosed vesicles with early endosomes. 
A few peptide-MHC complexes are enough to activate T cells, although a similar number of 
TCR complexes on the surface of T cells will not be sufficient to activate them. It was shown 
that this small number of peptide-MHC complexes could activate T cells because each complex 
is able to engage serially with up to 200 TCR molecules (Valitutti et al., 1995). This explains the 
requirement for the efficient endocytosis of the activated TCR complexes. Constitutively 
endocytosed TCR-CD3 complexes are recycled back to the plasma membrane (Minami et al., 
1987), however TCR-antigen ligation induces the disassembly of the CD3 ζ-chain from the 
TCR-CD3 complex (Liu et al., 2000), which is down regulated (Dietrich et al., 1994) whereas 
the ζ-chain is targeted for degradation (Dumont et al., 2002). The ζ-chain of the TCR-CD3 
complex follows a different metabolic pathway than the rest of the TCR-CD3 complex with 
different turnover times; the half-life for the ζ -chain is 4 hrs (Ono et al., 1995) and 20 hrs for the 
rest of the complex (Alcover and Alarcon, 2000; Dumont et al., 2002). ZAP70, a tyrosine kinase 
that binds to and phosphorylates residues of the CD3 ζ-chain is involved in the regulation of 
activated TCR-CD3 complexes and in down modulation and degradation of the ζ-chain (Dumont 
et al., 2002; Luton et al., 1994). This means that ZAP70 can be endocytosed along with ζ-chain, 
independently of the TCR-CD3 complex thereby supporting our data in which ZAP70 is 
endocytosed in the same nascent vesicle as endo-Syb2. Quantification of colocalization between 
ZAP70 and endo-Syb2 showed that both proteins were internalized in the same vesicle at least 
until after 15 min after target cell addition (Figure 12) (until they reach the early endosomes, see 
below). 
IV.3  Syb2 reaches the early endosomes within 15 min after addition of target 
cells 
Endocytosis has been widely studied for many different proteins utilizing different pathways of 
endocytosis. Generally, endocytosis occurs to regenerate membrane proteins or to endocytose 
receptor-bound ligands to increase or attenuate the signaling response depending on the 
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endocytosed receptor. The general pathway taken by proteins destined to be recycled e.g. the 
transferrin receptor (Watts, 1985) is through vesicles that fuse with the early endosomes and then 
from the early endosomes to the plasma membrane through recycling endosomes. Other proteins 
destined for degradation such as epidermal growth factor receptor (EGF-R) (Beguinot et al., 
1984) are endocytosed through vesicles that fuse with the early endosomes and then are 
transported to the degradative lysosomes through late endosomes.  
We have shown that different proteins are endocytosed along with Syb2 in the same vesicle, 
including other components of mature CGs (V-ATPase). In order to determine the pathway taken 
by endo-Syb2 through the different endocytic compartments, we transfected sybki CTLs with 
different markers of early, recycling and late endosomes, to label each of these endosomes, and 
examined their colocalization with endo-Syb2 (labeled with anti-RFP647). Anti-RFP647 was 
added to the medium containing CTL:target cell conjugates and cells were fixed at different 
times after target cell addition. We found that Syb2 arrives at the early endosomes 15 min after 
target cell addition. We observed maximum colocalization with eGFP-Rab5, our marker for early 
endosomes at this time. Colocalization between endo-Syb2 and eGFP-Rab5 was low after 5 min 
of CTL:target cell conjugation but reached a maximum after 15 min of target cell addition, and 
then it decreased at the 30 and 60 min time points (Figure 15). The early endosomes are known 
as sorting endosomes because they receive incoming cargo from the plasma membrane, which 
are then sorted to their destinations (Maxfield and McGraw, 2004). We show that it requires 
about 15 min of CTL:target cell contact for endo-Syb2 to reach the early endosomes.  
Syb2 along with its interacting t-SNAREs (SNAP-25 and syntaxin) undergo both slow (10-60 
seconds) and rapid (1-3 seconds) endocytosis at the calyx of held nerve terminus (Xu et al., 
2013). This neuronal synapse contains hundreds of synaptic vesicles that need to be replenished 
rapidly to maintain the high rate of synaptic vesicle fusion found at this synapse. The much 
slower endocytosis we have observed likely reflects the small numbers and slow rates of release 
of CGs in CTLs. 
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IV.4 Endo-Syb2 traffics through early endosomes and late endosomes but not 
recycling endosomes 
Cargo trafficked from the plasma membrane to the early endosomes is either recycled back to the 
plasma membrane via recycling endosomes (Rab11 positive), or trafficked further in the 
endosomal pathway to reach the late endosomes (Rab7 positive) (Rink et al., 2005). We 
transfected sybki CTLs with markers for recycling and late endosomes, then quantified the 
colocalization between endo-Syb2 (anti-RFP647) and either eGFP-Rab11 or eGFP-Rab7 using 
Manders’ coefficient for colocalization. Our results demonstrated weak colocalization between 
endo-Syb2 and eGFP-Rab11 at all time points of CTL:target cell conjugation (5, 15, 30 and 60 
min) (Figure 16). However, endo-Syb2 was colocalized with eGFP-Rab7 after 30 min, and 
colocalization was maximal at 60 min of CTL:target cell conjugation (Figure 17).  
These data show that Syb2 traffics from early endosomes to late endosomes, but not to recycling 
endosomes. Endocytosis of most proteins studied in immune cells follows the recycling 
endosomal pathway. Peptide-loaded MHC-II receptors (pMHC-II) fuse with early endosomes 
upon internalization where they are probably reloaded with new peptides and then recycled to 
present their new cargo at the plasma membrane (Walseng et al., 2008). Constitutively 
endocytosed CD3-TCR complexes are also transported mainly through the recycling endosomes 
(Minami et al., 1987). Lamp-1 an important constituent of CGs, that also constitutes about 50% 
of the lysosomal membrane proteins, recycles in activated CTLs in an exo-endocytic cycle 
starting at the IS (Liu et al., 2009). Proteins important for the fusion of CG, like the priming 
factor munc13-4 have also been shown to be recycled after CG fusion at the IS to aid in the serial 
killing of the CTL or NK cells (Capuano et al., 2012). Therefore, our findings indicate a pathway 
that is not widely used by recycling proteins of lymphocytes. Recycling endosomes fuse with the 
plasma membrane to deliver plasma membrane resident proteins or proteins that need to function 
at the plasma membrane (Marshall et al., 2015). Since Syb2 is a CG membrane resident protein it 
should follow a different path. CGs, also known as secretory lysosomes might mature from late 
endosomes or multivesicular bodies (MVBs), as do conventional lysosomes. Electron 
microscope images have in fact demonstrated MVBs and late endosomes to have varying 
electron dense core, representing different maturation stages with CGs having the most dense 
core. 
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 Although, non-CG resident proteins are endocytosed along with Syb2 in the same vesicle at 
least till early/sorting endosomes, we tested another CG membrane protein, the V-ATPase 
(probably only V0 domain), and found it to be endocytosed along with Syb2 in the same vesicle 
at least until it reaches the early endosomes. It would be interesting to see if the colocalization 
between endo-Syb2 and non-resident CG proteins decreases within 60 minutes of target cell 
addition where most of the endo-Syb2 is in the late endosomes (section III.3.3). 
IV.5  Endo-Syb2 vesicles acquire granzyme B at the late endosomes to become 
a fully mature vesicle 
Fully mature CGs contain Syb2 as a v-SNARE (Matti et al., 2013) and contain the cytotoxic 
proteins perforin and granzymes among other proteins that give the CGs their characteristic 
dense core (Matti et al., 2013). Our data showed that endo-Syb2 vesicles fuse with the early 
endosomes after 15 min of target cell addition and with late endosomes after 30-60 min showing 
maximum colocalization within 60 min. We followed the maturation of endo-Syb2 after 
endocytosis and investigated when and where granzyme B is incorporated. Our data show that 
Syb2 proceeds from the early endosomes to late endosomes and not through recycling 
endosomes, we tested whether endo-Syb2 would colocalize with granzyme B either in early or 
late endosomes. Data analysis was done by calculating the colocalization between three proteins 
namely endo-Syb2, granzyme B and Rab5/7. The number of endo-Syb2 pixels that colocalized 
with Rab5 or Rab7 fluorescent pixels and also contained granzyme B fluorescent pixels was 
calculated for various time points (Figures 17 and 18, respectively). We found that Syb2 
colocalizes with granzyme B at the late endosomal stage and not at the early endosomal stage, 
where it shows maximum colocalization with granzyme B after 60 min of target cell addition, the 
same time that is required for Syb2 to colocalize maximally with late endosomes.  
Newly synthesized granzyme B is transported from the trans-Golgi network (TGN) to the late 
endosomes via mannose-6-phosphate receptor (M6PR) (Griffiths and Isaaz, 1993). CGs 
discharge their entire content of granzyme B upon fusion, indicating that these vesicles need to 
be refilled with granzyme B to be competent for killing (Chang et al., 2016). From the current 
experiments, we see that Syb2 associates again with granzyme B at the late endosomes, which is 
likely the final maturation. It has been suggested that granzyme B-containing vesicles fuse with 
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Rab11/Rab27/Munc13-4 positive vesicles before they fuse with the plasma membrane (Menager 
et al., 2007). In Our experiments, Rab27 is present on newly synthesized CGs even in 
unconjugated CTLs, and is present on CGs that have not polarized to the IS in conjugated CTLs 
(data not shown). For NK cells, Rab11-positive recycling endosomes (REs) did not associate 
with CGs at the NK cell synapse and the inactivation of REs did not affect the release of 
preformed mature NK cell granules, but it is suggested that REs might be involved in earlier 
maturation steps of CG formation (Reefman et al., 2010). The authors of this paper also showed 
that REs were functionally required for the surface delivery and release of cytokines (TNFa and 
INFgamma) (Reefman et al., 2010).  
Proteins destined for degradation are transported from the late endosomes to lysosomes (Huotari 
and Helenius, 2011). Huotari et al referred to the lysosomal compartment where degradation of 
endocytosed proteins takes place as the endolysosome, because these organelles are the result of 
fusion between late endosomes and lysosomes. However, several proteins including M6PR and 
some SNARE proteins do not necessarily follow this pathway and might escape degradation in 
the endolysosome, probably by fusing with the lysosomal compartment that has the dense core 
with all proteins necessary for maturation of CGs or by escaping lysosomal degradation via 
vesicular trafficking (Huotari and Helenius, 2011). For example, Rab9 is involved in the 
recycling of M6PRs from the late endosomes to the TGN through interacting with its effector 
TIP47 (Carroll et al., 2001). Consistent with the maturation of endo-Syb2 vesicles by acquiring 
granzyme B at the late endosomes within 60 min of target cell addition, these vesicles were also 
shown to polarize to a second IS formed by the CTL, with the same time range, indicating that 
these vesicles are again ready to fuse and kill their target (Chang et al., 2016). We show that 
Syb2 doesn’t undergo the classical trafficking from late endosomes to endolysosomes to be 
degraded, but is rather further trafficked from the late endosomes either directly into a fully 
mature CG or might acquire further lysosomal proteins from the lysosomal dense core to be 
capable of another round of fusion. 
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IV.6  Model for Syb2 endocytosis 
Activation of CTLs for killing of target cells is initiated by the recognition of foreign peptides 
presented on MHC-I molecule on the surface of the target cell (pMHC-I) by the T cell receptor 
(TCR). TCR-pMHC-I interaction leads to the activation of the TCR-CD3 complex and 
recruitment of different kinases that phosphorylate residues important for activating other 
proteins involved in signaling pathway activation. One such kinase is the protein tyrosine kinase 
ZAP70. It binds to the ζ-chain of the CD3 receptor, initiating the signaling cascade, which is 
followed by recruitment of the cytotoxic granules (CGs) to the newly formed IS. Fully mature 
CGs containing cytotoxic proteins are acidic with pH around 4.5-5.5 maintained by the function 
of the V-ATPase. Polarized CGs ready for fusion have their V1 domain dissociated from the V-
ATPase complex, leaving the V0 domain integrated in the CG membrane where it might interact 
with the forming SNARE complex upon CG fusion. After CG fusion, the CG membrane proteins 
diffuse in the plasma membrane. NSF disassembles the SNARE complex into the single proteins, 
which appear to remain in close proximity at the plasma membrane to be endocytosed together in 
one vesicle as we have seen for Syb2 and SNAP-23. Also the ζ-chain of the TCR-CD3 complex, 
along with the bound ZAP70, dissociates from the complex and is probably endocytosed along 
with Syb2 in the same vesicle. From previous studies it was shown that V0 of the V-ATPase is 
free from V1 upon synaptic vesicle fusion. We suggest that this is the case also for CGs and the 
V0 domain of the V-ATPase is endocytosed along with Syb2 in the same vesicle. After one to 
two minutes of Syb2 exposure at the plasma membrane these components are endocytosed into 
one vesicle as the V1 then associates with the V0 domain to form a functional V-ATPase that 
starts to gradually increase the acidity of the endocytic vesicle. Within 15 min this endocytic 
vesicle fuses with the early endosomes where some of its components might then diffuse with 
the early endosomal membrane, taking a different endocytic pathway than Syb2. At least one 
other CG membrane protein, the V-ATPase, remains in the same endocytic vesicle as Syb2. 
After 30 to 60 min endo-Syb2 vesicles arrive at the late endosomes where they acquire 
granzyme B. The CGs then acquire LAMP proteins and other proteins required for killing 
activity, most likely by fusing with lysosomes (CGs are also known as secretory lysosomes), or 
with the late endosomes, where they then bud out forming mature CGs. These mature CGs are 
then capable of another round of fusion with the plasma membrane and capable of killing 
another target cell (Figure 20). 
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Figure 20. Model for Syb2 endocytosis through the endosomal pathway.  
CG fusion is effected by the formation of the SNARE complex comprised of the v-SNARE, Syb2 and the 
t-SNAREs, SNAP-23 and syntaxin. CG exocytosis leads to the diffusion of Syb2 with the plasma membrane. Syb2 
is then endocytosed with the V0 domain of the V-ATPase along with other proteins in the same vesicle, including 
ZAP70 and SNAP-23. Directly after endocytosis the V1 domain associates with V0 domain of the V-ATPase to 
form a functional proton pump that acidifies the endocytic vesicle. The latter then arrives 15 min later at the early 
endosomes. From the early endosomes, Syb2 is further trafficked along with the V-ATPase to reach late endosomes 
in 30 to 60 min after endocytosis. At the late endosomes, Syb2 associates with granzyme B into one vesicle and 
might acquire lysosomal proteins either at late endosomes or by further fusing with lysosomes. This is considered to 
be the final maturation step of the CG that is then capable of another round of fusion.  
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V.  Outlook 
We have elucidated the pathway for maturation of a CG membrane component, Syb2, until it is 
incorporated into a mature CG ready for a second round of fusion. Replenishment of mature CGs 
is critical for the serial killing function of CTLs, thus any disturbance in CG maturation from its 
endocytosed components would lead to serious malfunctioning of the CTLs. Identifying the 
mechanism of Syb2 (a main component of CGs) endocytosis, gives us more insight into the 
deregulation that might occur along the way of their maturation. 
To better understand Syb2 interactions during CG fusion, further experiments are required to 
identify other interacting t-SNAREs, whether it’s STX11 or other syntaxin that is required for 
CG fusion in mouse CTLs. Also it would be interesting to follow up whether SNAP-23 is 
recycled to the plasma membrane directly from early endosomes via recycling endosomes, which 
would indicate that it might be endocytosed with Syb2 in the same vesicle because it is required 
for the fusion of this vesicle with early endosomes; after fusion with early endosomes, SNAP-23 
would be incorporated into recycling endosomes to be recycled again to the plasma membrane. 
A very interesting experiment would be to check how and when do mature endo-Syb2 vesicles 
fuse with the plasma membrane. This experiment might be done using TIRF microscopy to 
check for the fusion of endo-Syb2 vesicles, or using live cell imaging with target cells and using 
for example, a pH-dependent fluorophore coupled to anti-RFP antibody that can identify, 
initially endocytosed vesicles, and then mature endo-Syb2 vesicles that undergo fusion and lose 
their fluorescence due to change in their pH upon fusion.  
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VI. Summary 
Cytotoxic T lymphocytes (CTLs) kill target cells by releasing the content of their cytotoxic 
granules (CGs). CTLs are known as serial killers due to their ability to kill multiple target cells. 
Serial killing requires that CTLs replenish their CGs to be available for a new round of killing. 
Newly produced CGs could be formed by de novo synthesis or by recycling of their components 
to ensure fast replenishment of mature CGs. To better understand the mechanism of recycling of 
CG components, we studied the endocytosis pathway of synaptobrevin2 (Syb2), the v-SNARE 
present on CGs of murine CTLs. In order to specifically follow up Syb2 we used CTLs from 
Syb2-mRFP knock-in (sybki) mice and utilized anti-RFP antibody to track Syb2-mRFP (Shortly, 
Syb2) after CG fusion and Syb2 exposure at the plasma membrane. 
We started our study from the point of CG fusion with the plasma membrane. Using co-
immunoprecipitation, we found that Syb2 interacts with synaptosomal-associated protein-23 
(SNAP-23) during SNARE complex formation to initiate fusion of CGs with the plasma 
membrane, indicating that SNAP-23 is a t-SNARE required for CG fusion. After exposure of 
Syb2 at the plasma membrane upon CG fusion, the mRFP fused to Syb2 faces to the 
extracellular medium. Utilizing fluorescently-labeled anti-RFP antibody allows for tracking the 
endocytic pathway followed by Syb2. We identified some proteins that were endocytosed with 
Syb2 in the same vesicle, at least until it fuses with early endosomes. Proteins endocytosed with 
Syb2 include the t-SNARE SNAP-23, zeta-chain associated 70 kDa tyrosine phosphoprotein 
(ZAP70) and a CG membrane protein the H+ V-ATPase. These results were shown using high 
resolution imaging of fixed cells at different time points. Endocytosis of the V-ATPase with 
Syb2 in the same vesicle was further verified using live cell imaging, where the acidification of 
endocytosed Syb2-containing (endo-Syb2) vesicles occurred within one to two minutes (min) of 
Syb2 exposure at the plasma membrane. Endo-Syb2 arrives at the early endosomes within 15 
min of target cell addition; shown by its colocalization with eGFP-Rab5, the early endosomal 
marker. From the early endosomes, endo-Syb2 further traffics to late endosomes within 60 min 
of target cell addition but not through recycling endosomes, also shown by its colocalization with 
eGFP-Rab7 but not with eGFP-Rab11, the markers for late and recycling endosomes, 
respectively. In order to investigate whether endo-Syb2 vesicles would undergo maturation to 
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become fully mature CGs, we tested whether they would regain granzyme B, the marker of 
mature CGs, when and where. We found that endo-Syb2 vesicles colocalized with granzyme B at 
the late endosomes within 60 min of target cell addition, at the time where endo-Syb2 shows 
maximum colocalization with late endosomes. 
Our study identifies SNAP-23 as a t-SNARE interacting with the v-SNARE Syb2 to initiate CG 
fusion. It further shows that Syb2 is endocytosed along with other components of CGs where this 
might be important for the replenishment of fully mature CGs containing granzyme B and ready 
for another round of target cell killing, a critical aspect of CTL function. 
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